<?xml version='1.0' encoding='UTF-8'?>
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="review-article">
  <?properties open_access?>
  <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
    <restricted-by>pmc</restricted-by>
  </processing-meta>
  <front><journal-meta><journal-id journal-id-type="nlm-ta">Nat Sci Sleep</journal-id><journal-id journal-id-type="iso-abbrev">Nat Sci Sleep</journal-id><journal-id journal-id-type="publisher-id">nss</journal-id><journal-title-group><journal-title>Nature and Science of Sleep</journal-title></journal-title-group><issn pub-type="epub">1179-1608</issn><publisher><publisher-name>Dove</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">38090631</article-id><article-id pub-id-type="pmc">10712264</article-id><article-id pub-id-type="publisher-id">401271</article-id><article-id pub-id-type="doi">10.2147/NSS.S401271</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Investigating the Role of BDNF in Insomnia: Current Insights</article-title><alt-title alt-title-type="running-authors">Ditmer et al</alt-title><alt-title alt-title-type="running-title">Ditmer et al</alt-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Ditmer</surname><given-names>Marta</given-names></name><xref rid="aff0001" ref-type="aff">1</xref><xref rid="ft0001" ref-type="author-notes">*</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Gabryelska</surname><given-names>Agata</given-names></name><xref rid="aff0001" ref-type="aff">1</xref><xref rid="ft0001" ref-type="author-notes">*</xref></contrib><contrib contrib-type="author"><name><surname>Turkiewicz</surname><given-names>Szymon</given-names></name><xref rid="aff0001" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Sochal</surname><given-names>Marcin</given-names></name><xref rid="aff0001" ref-type="aff">1</xref><xref rid="an0001" ref-type="corresp"/></contrib><aff id="aff0001"><label>1</label><institution>Department of Sleep Medicine and Metabolic Disorders, Medical University of Lodz</institution>, <addr-line>Lodz</addr-line>, <addr-line>92-215</addr-line>, <country>Poland</country></aff></contrib-group><author-notes><corresp id="an0001">Correspondence: Marcin Sochal, <institution>Department of Sleep Medicine and Metabolic Disorders, Medical University of Lodz</institution>, <addr-line>Lodz</addr-line>, <addr-line>92-215</addr-line>, <country>Poland</country>, <phone>Tel +48 661 475 310</phone>, Email sochalmar@gmail.com</corresp><fn id="ft0001"><label>*</label><p><citation_analysis attribute="neither">These authors contributed equally to this work</citation_analysis></p></fn></author-notes><pub-date pub-type="epub"><day>07</day><month>12</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>15</volume><fpage>1045</fpage><lpage>1060</lpage><history><date date-type="received"><day>28</day><month>7</month><year>2023</year></date><date date-type="accepted"><day>28</day><month>11</month><year>2023</year></date></history><permissions><copyright-statement>© 2023 Ditmer et al.</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Ditmer et al.</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/3.0/</ali:license_ref><license-p>This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at <ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link> and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (<ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link>).</license-p></license></permissions><abstract><title>Abstract</title><p><citation_analysis attribute="neither">Insomnia is a common disorder defined as frequent and persistent difficulty initiating, maintaining, or going back to sleep. A hallmark symptom of this condition is a sense of nonrestorative sleep. It is frequently associated with other psychiatric disorders, such as depression, as well as somatic ones, including immunomediated diseases. BDNF is a neurotrophin primarily responsible for synaptic plasticity and proper functioning of neurons. Due to its role in the central nervous system, it might be connected to insomnia of multiple levels, from predisposing traits (neuroticism, genetic/epigenetic factors, etc.) through its influence on different modes of neurotransmission (histaminergic and GABAergic in particular), maintenance of circadian rhythm, and sleep architecture, and changes occurring in the course of mood disturbances, substance abuse, or dementia. Extensive and interdisciplinary evaluation of the role of BDNF could aid in charting new areas for research and further elucidate the molecular background of sleep disorder. In this review, we summarize knowledge on the role of BDNF in insomnia with a focus on currently relevant studies and discuss their implications for future projects.</citation_analysis></p></abstract><kwd-group kwd-group-type="author"><title>Keywords</title><kwd>sleep</kwd><kwd>insomnia</kwd><kwd>brain-derived neurotrophic factor</kwd></kwd-group><counts><fig-count count="1"/><table-count count="1"/><ref-count count="146"/><page-count count="16"/></counts></article-meta></front>
  <body>
    <sec sec-type="intro" id="s0001">
      <title>Introduction</title>
      <p><citation_analysis attribute="positive">Sleep is vital to cognitive performance and overall health, and sleep disturbances are known to significantly decrease life quality as well as affect the course of other diseases. For example, sleep disorders have been demonstrated to be a risk factor for disease relapse in ulcerative colitis patients.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0001" ref-type="bibr">1</xref></citation_analysis><citation_analysis attribute="negative"> In a South Korean study, patients with sleep disorders had a higher risk of developing immunomediated disorders, such as alopecia areata, Graves disease, or Hashimoto thyroiditis.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0002" ref-type="bibr">2</xref></citation_analysis><citation_analysis attribute="negative"> According to Young et al, sleeping &lt;7 hours per night puts individuals at a higher risk of developing systemic lupus erythematosus.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0003" ref-type="bibr">3</xref></citation_analysis><citation_analysis attribute="neither"> Interestingly, Sang et al found no association between genetically determined insomnia (125 single-nucleotide polymorphisms identified by the authors) and systemic lupus erythematosus, which suggests that the relationship between the two is dynamic and could involve external factors, such as lifestyle and environment.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0004" ref-type="bibr">4</xref></citation_analysis><citation_analysis attribute="negative"> Poor sleep quality is also an important risk factor for depression relapse.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0005" ref-type="bibr">5</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">The American Academy of Sleep Medicine defines insomnia disorder as frequent and persistent difficulty initiating, maintaining, or going back to sleep in spite of the right conditions, which results in nonrestorative sleep.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0006" ref-type="bibr">6</xref></citation_analysis><citation_analysis attribute="neither"> Insomnia disorder is usually associated with some level of impairment in other domains of life. The cutoff point between chronic and short-term insomnia is 3 months, and symptoms should occur at least 3 times a week.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0006" ref-type="bibr">6</xref></citation_analysis><citation_analysis attribute="neither"> Insomnia prevalence varies between studies. Depending on the population and assumed diagnostic criteria, it appears to be 10%–30%.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0007" ref-type="bibr">7</xref></citation_analysis><citation_analysis attribute="neither"> It can be a primary disease or a symptom of another condition, such as restless leg syndrome (RLS) or periodic leg movements during sleep. Insomnia also frequently accompanies psychiatric disorders and immunomediated diseases.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0008" ref-type="bibr">8–10</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">The causes of insomnia remain elusive. Insomnia might have genetic predisposing factors, as familial aggregation has been observed.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0011" ref-type="bibr">11</xref></citation_analysis><citation_analysis attribute="negative"> Insomnia appears to be tightly related to stress-response and coping mechanisms. The term “sleep reactivity” describes individual propensity to sleep disruptions in response to stressful situations. This trait alongside neuroticism is a risk factor for insomnia development.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0011" ref-type="bibr">11</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0012" ref-type="bibr">12</xref></citation_analysis><citation_analysis attribute="neither"> Currently, one of the most popular models of insomnia, developed by Spielman et al in 1987, identifies three types of factors at play: predisposing, precipitating, and perpetuating.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0013" ref-type="bibr">13</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">The cornerstone of insomnia treatment is cognitive–behavioral therapy (CBT). CBT focuses on developing certain adaptive strategies, like control of stimuli, relaxation techniques, and coping with stress.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0014" ref-type="bibr">14</xref></citation_analysis><citation_analysis attribute="neither"> This approach is effective and results are sustainable over time.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0014" ref-type="bibr">14</xref></citation_analysis><citation_analysis attribute="neither"> In their guidelines, the European Sleep Research Society also approves the use of some antidepressants (eg, doxepin, mianserin, mirtazapine, trazodone), benzodiazepine-receptor agonists (Z-drugs), and benzodiazepines.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0015" ref-type="bibr">15</xref></citation_analysis><citation_analysis attribute="positive"> Commonly used antihistamines and melatonin are not recommended due to the low quality of available evidence in favor of their use.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0015" ref-type="bibr">15</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">BDNF is a neurotrophin ubiquitous in the central nervous system (CNS), particularly in the prefrontal cortex and the limbic regions, with the highest levels detected in the hippocampus.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0016" ref-type="bibr">16</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0017" ref-type="bibr">17</xref></citation_analysis><citation_analysis attribute="neither"> Outside the CNS it is also found in the heart, lungs, and liver.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0017" ref-type="bibr">17</xref></citation_analysis><citation_analysis attribute="neither"> As a neurotrophic factor, BDNF is responsible for growth and development of neurons, promoting neuro- and gliogenesis.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0018" ref-type="bibr">18</xref></citation_analysis><citation_analysis attribute="neither"> BDNF also has antiapoptotic properties; it stimulates the sonic hedgehog and erythropoietin and promotes the expression of Bcl-2 proteins, which together prevent cell death.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0019" ref-type="bibr">19</xref></citation_analysis><citation_analysis attribute="positive"> Neurotrophin might also exert antioxidative and antiautophagy effects through ERK1/2 and PI3K/Akt pathways, respectively.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0019" ref-type="bibr">19</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">BDNF is vital for neuroplasticity: it affects the development of new synapses by modulating synaptic arborization and morphogenesis, thus promoting formation of new neuronal circuits and improving cognitive function.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0020" ref-type="bibr">20</xref></citation_analysis><citation_analysis attribute="neither"> It also controls glutamatergic transmission by regulating the activity and expression of </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">N</italic></citation_analysis><citation_analysis attribute="neither">-methyl-</citation_analysis><citation_analysis attribute="positive"><bold><sc>d</sc></bold></citation_analysis><citation_analysis attribute="neither">-aspartate receptors (NMDARs), associated with enhanced memory formation.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0017" ref-type="bibr">17</xref></citation_analysis><citation_analysis attribute="positive"> Therefore, it is likely to confer some of the benefits of sleep, such as memory consolidation.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0018" ref-type="bibr">18</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">Disruptions in BDNF signaling have long been associated with psychiatric disorders, such as dementia or depression, which are frequently accompanied by insomnia.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0021" ref-type="bibr">21</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0022" ref-type="bibr">22</xref></citation_analysis><citation_analysis attribute="positive"> Patients with Alzheimer’s disease have been shown to have lower levels of this neurotrophin in brain, blood, and cerebrospinal fluid. Moreover, increased serum BDNF was associated with better cognitive faculties in this group.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0023" ref-type="bibr">23</xref></citation_analysis><citation_analysis attribute="positive"> Similar observations have been made in patients with major depressive disorders: treatment with antidepressant drugs or electroconvulsive therapy brought about significant improvements in BDNF levels.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0024" ref-type="bibr">24</xref></citation_analysis><citation_analysis attribute="neither"> BDNF might also be directly involved in the course of insomnia.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0018" ref-type="bibr">18</xref></citation_analysis><citation_analysis attribute="neither"> It shows a strong connection to sleep architecture, the sleep–wake cycle, and comorbidities of this sleep disorder.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0018" ref-type="bibr">18</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">This review aims to investigate the role of BDNF in insomnia and other selected subjects related to this sleep disorder (eg, circadian rhythm, neurodenerative conditions), with a focus on currently relevant studies. We discuss the relationship between BDNF, the sleep–wake cycle, circadian rhythm, the basis of an inherent propensity to insomnia, and the interplay between stress response and the titular neurotrophin.</citation_analysis></p>
    </sec>
    <sec id="s0002">
      <title>Neurobiology of BDNF</title>
      <p><citation_analysis attribute="neither">BDNF was discovered in 1982 by Yves Barde and Hans Thoenen.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0025" ref-type="bibr">25</xref></citation_analysis><citation_analysis attribute="neither"> It is a member of the neurotrophin family, and its structure bears a high degree of similarity to other neurotrophins, such as nerve growth factor (NGF), neurotrophin 3, and neurotrophin 4/5. The </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes"><bold>BDNF</bold></italic></citation_analysis><citation_analysis attribute="neither"> gene is located on the 11p chromosome.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0018" ref-type="bibr">18</xref></citation_analysis><citation_analysis attribute="neither"> It has five exons, with only the 3’ exon coding for the BDNF protein.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0018" ref-type="bibr">18</xref></citation_analysis><citation_analysis attribute="neither"> Transcription of the remaining is tissue-dependent, with exons I–III dominating in different regions of the central nervous system, mainly the cortex and the hippocampus.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0018" ref-type="bibr">18</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">BDNF’s cognate receptor is tropomyosin receptor kinase B (TrkB).</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0018" ref-type="bibr">18</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0026" ref-type="bibr">26</xref></citation_analysis><citation_analysis attribute="neither"> Upon binding of the ligand, TrkB dimerizes and recruits other pathways, such as the MEK–MAPK pathway, ERK pathway, PLCγ pathway, and PI3K–Akt–mTOR pathway.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0018" ref-type="bibr">18</xref></citation_analysis><citation_analysis attribute="positive"> The PI3K–Akt–mTOR pathway might be of particular importance to the prosurvival effect BDNF has on neurons, as it is associated with autophagy and has been demonstrated to protect neuronal cells from hypoxic damage.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0018" ref-type="bibr">18</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0027" ref-type="bibr">27</xref></citation_analysis><citation_analysis attribute="neither"> BDNF might also attenuate activation of microglia, preventing them from releasing proinflammatory cytokines and toxins that could damage neurons.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0028" ref-type="bibr">28</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">BDNF is one of the major factors contributing to synaptic plasticity, which is strengthening or weakening synaptic connections, a process underlying learning or memory formation.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0029" ref-type="bibr">29</xref></citation_analysis><citation_analysis attribute="positive"> Inhibition of this pathway has been shown to reduce synaptogenic activity of the synapsin I and NMDAR pathway.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0029" ref-type="bibr">29</xref></citation_analysis><citation_analysis attribute="positive">
</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">BDNF</italic></citation_analysis><citation_analysis attribute="neither">-knockout animals display decreased synaptic density to sympathetic neurons.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0030" ref-type="bibr">30</xref></citation_analysis><citation_analysis attribute="neither"> In contrast, stimulation of the BDNF pathway promotes dendrite arborization, while dendrite branching is enhanced by TrkB and MAPK pathway–mediated cypin expression.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0031" ref-type="bibr">31–35</xref></citation_analysis></p>
      <p><citation_analysis attribute="positive">The BDNF pathway is strongly connected to glutamatergic neurotransmission. It has been demonstrated to regulate the amount of glutamate released to the synapse via MAPK-dependent synapsin I phosphorylation, as well as an increase in intracellular Ca2</citation_analysis><citation_analysis attribute="positive"><sup>+</sup></citation_analysis><citation_analysis attribute="neither"> concentration.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0036" ref-type="bibr">36–38</xref></citation_analysis><citation_analysis attribute="neither"> It also interacts with the postsynaptic glutamate receptors NMDAR and α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor, promoting their phosphorylation.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0039" ref-type="bibr">39–41</xref></citation_analysis><citation_analysis attribute="neither"> It might exert a protective influence against glutamate excitotoxicity via the Ras–MAPK and PI3K–Akt pathways.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0042" ref-type="bibr">42</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">BDNF is also connected to γ-aminobutyric acid (GABA) signaling. It controls the expression of the GABA synthetic enzyme GAD65.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0043" ref-type="bibr">43</xref></citation_analysis><citation_analysis attribute="neither"> BDNF also inhibits endocytosis of GABA</citation_analysis><citation_analysis attribute="positive"><sub>A</sub></citation_analysis><citation_analysis attribute="neither">R, a metabotropic GABA receptor, via PI3K, including its downstream target PP2A and PKC pathways.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0043" ref-type="bibr">43</xref></citation_analysis><citation_analysis attribute="neither"> ProBDNF has the opposite effect, promoting endocytosis of GABA</citation_analysis><citation_analysis attribute="positive"><sub>A</sub></citation_analysis><citation_analysis attribute="neither">R β3 subunits through the RhoA–Rock–PTEN pathway.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0043" ref-type="bibr">43</xref></citation_analysis><citation_analysis attribute="neither"> As already mentioned, a majority of neurons in the suprachiasmatic nucleus (SCN) are GABAergic; therefore, it is possible that BDNF fulfills there a major role controlling communication between cells.</citation_analysis></p>
      <p><citation_analysis attribute="positive">It could be suspected that orexin signaling is related to BDNF. This neuropeptide was demonstrated to prompt the expression of the neurotrophin via activation of the OX1R-related pathways: PI3K and PKC.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0044" ref-type="bibr">44</xref></citation_analysis><citation_analysis attribute="positive"> Interestingly, mice bereft of another orexin receptor, OX2R, were shown to have more depressive behavior than healthy ones. This could be caused by an in increase in BDNF expression mediated by OX2R-mediated stimulation of the CREB pathway.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0044" ref-type="bibr">44</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0045" ref-type="bibr">45</xref></citation_analysis><citation_analysis attribute="neither"> Due to the importance of orexin for histaminergic signaling as well as wakefulness, future studies on the role of BDNF in the context of discussed neuropeptides are validated.</citation_analysis></p>
      <sec id="s0002-s2001">
        <title>BDNF and Sleep Regulation</title>
        <p><citation_analysis attribute="positive">Sleep is a complex, involving specific brain activity, which can be shown on electroencephalography (EEG). Sleep architecture is a term describing changes in the EEG patterns seen through the night.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0046" ref-type="bibr">46</xref></citation_analysis><citation_analysis attribute="neither"> Two main stages of sleep are non–rapid eye movement (NREM) and REM phases.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0046" ref-type="bibr">46</xref></citation_analysis><citation_analysis attribute="neither"> NREM can be further divided into three stages, N1–N3: N2b and N3 are described as slow-wave sleep (SWS).</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0046" ref-type="bibr">46</xref></citation_analysis><citation_analysis attribute="neither"> Apart from eye movement, those two distinctly differ in terms of muscle tone and heart and respiratory rate.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0046" ref-type="bibr">46</xref></citation_analysis><citation_analysis attribute="neither"> Slow-wave activity (SWA) is characterized by EEG power between 0.5 and 4 Hz.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0046" ref-type="bibr">46</xref></citation_analysis><citation_analysis attribute="neither"> Sleep progresses in cycles between those phases, usually four to five per night.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0046" ref-type="bibr">46</xref></citation_analysis></p>
        <p><citation_analysis attribute="neither">Sleep architecture varies on an individual basis, depending on factors like age, sex or drug use.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0046" ref-type="bibr">46</xref></citation_analysis><citation_analysis attribute="neither"> Its alterations have been observed in numerous conditions, including insomnia.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0046" ref-type="bibr">46–49</xref></citation_analysis><citation_analysis attribute="neither"> Even though polysomnography is not a diagnostic method for insomnia, changes in sleep architecture might affect one’s perception of sleep duration and its quality, and thus factors shaping sleep structure need to be studied.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0046" ref-type="bibr">46</xref></citation_analysis><citation_analysis attribute="positive"> Literature on the subject shows that BDNF might modulate sleep structure. Intraventricular administration of BDNF was demonstrated to increase the duration of both REM and NREM sleep in rabbits, but only NREM in rats.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0050" ref-type="bibr">50</xref></citation_analysis><citation_analysis attribute="neither"> What is interesting is that changes in sleep architecture in mice with decreased BDNF production due to heterozygosity negatively affect only REM sleep, while NREM is unaltered.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0051" ref-type="bibr">51</xref></citation_analysis><citation_analysis attribute="neither"> This includes decreased overall REM duration and number of phases and increased REM initiation.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0051" ref-type="bibr">51</xref></citation_analysis></p>
        <p><citation_analysis attribute="neither">A decrease in BDNF production caused by the Val66Met BDF single-nucleotide polymorphism rs6265, present in 25%–30% of the population, is associated with prolonged initiation and termination of SWA (a type of EEG oscillation present primarily during NREM that is enhanced proportionally by the duration of wake time preceding sleep, a marker of sleep need).</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0052" ref-type="bibr">52–54</xref></citation_analysis><citation_analysis attribute="neither"> Moreover, those individuals display reduced SWS duration and sleep activity (as measured by delta activity).</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0054" ref-type="bibr">54</xref></citation_analysis><citation_analysis attribute="neither"> In a study on patients with major depressive disorder, it was revealed that upregulated BDNF production was linked to more intense SWA and higher NREM sleep quality; however, the level of this neurotrophin did not bear any relation to insomnia in this group.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0055" ref-type="bibr">55</xref></citation_analysis></p>
        <p><citation_analysis attribute="neither">The mechanism behind BDNF’s action on sleep architecture remains elusive. Some researchers maintain it has little, if any, influence on SWA.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0056" ref-type="bibr">56</xref></citation_analysis><citation_analysis attribute="positive"> The mode of BDNF administration seems to be an important modulator of the effects exerted by this protein. Intracortical administration has been shown to enhance SWA, while intraventricular BDNF injections led to SWA reduction.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0050" ref-type="bibr">50</xref></citation_analysis><citation_analysis attribute="neither"> It is plausible that the intraventricular mode of injection affect other structures controlling sleep.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0057" ref-type="bibr">57</xref></citation_analysis><citation_analysis attribute="neither"> Faraguna et al posited that BDNF is the interface between synaptic plasticity and SWA.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0057" ref-type="bibr">57</xref></citation_analysis><citation_analysis attribute="neither"> In a study on rats, animals who displayed more exploratory behavior had higher SWA than their less inquisitive counterparts.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0057" ref-type="bibr">57</xref></citation_analysis><citation_analysis attribute="neither"> Moreover, SWA, BDNF production, and exploratory behavior were positively correlated.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0057" ref-type="bibr">57</xref></citation_analysis></p>
        <p><citation_analysis attribute="neither">In contrast to the aforementioned studies, Watson et al hypothesized that the BDNF pathway has a greater role in modulation of REM sleep, rather than NREM.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0050" ref-type="bibr">50</xref></citation_analysis><citation_analysis attribute="neither"> Mice lacking a form of BDNF receptor TrkB T1 (truncated isoform without the tyrosine kinase domain), did not exhibit any changes in NREM, but REM sleep in this group was profoundly distorted. The researchers noted an increase in REM duration, decrease in REM sleep latency, and sleep fragmentation.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0050" ref-type="bibr">50</xref></citation_analysis><citation_analysis attribute="neither"> Those changes resembled the ones seen in patients with depression.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0050" ref-type="bibr">50</xref></citation_analysis><citation_analysis attribute="neither"> In vivo inhibition of the BDNF pathway brought contrasting results, decreasing the number of REM duration and episodes.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0058" ref-type="bibr">58</xref></citation_analysis><citation_analysis attribute="neither"> BDNF might also be involved in regulation of REM sleep drive: mice with decreased BDNF production after selective REM sleep deprivation do not experience rebound REM sleep.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0051" ref-type="bibr">51</xref></citation_analysis><citation_analysis attribute="positive"> This is in line with other studies, which showed that receptors for BDNF can be found in GABAergic and glutamatergic neurons of the midbrain and the brain stem important for sleep regulation. The pedunculopontine tegmentum, located in the upper brain stem, in particular was demonstrated to be vital for REM drive.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0051" ref-type="bibr">51</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0059" ref-type="bibr">59</xref></citation_analysis></p>
      </sec>
      <sec id="s0002-s2002">
        <title>BDNF and Circadian Rhythm</title>
        <p><citation_analysis attribute="neither">Circadian rhythm is a biological clock that follows a 24-hour cycle. It regulates alertness/sleepiness, metabolism, behavior, etc.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0060" ref-type="bibr">60</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0061" ref-type="bibr">61</xref></citation_analysis><citation_analysis attribute="neither"> The role of the central master clock is fulfilled by the SCN, which coordinates secondary peripheral oscillators in the tissues.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0060" ref-type="bibr">60</xref></citation_analysis><citation_analysis attribute="neither"> When endogenous circadian rhythm is altered or there occurs a misalignment between external factors and sleep–wake cycle (eg, shift work), circadian rhythm sleep disorder (CRSDs) might develop.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0062" ref-type="bibr">62</xref></citation_analysis><citation_analysis attribute="neither"> These include conditions like advanced/delayed/irregular sleep–wake phase disorder or shift-work sleep disorder. Due to similar symptomatology to insomnia, there are discussions on whether they should be classified together or regarded as a separate group of sleep disturbances. This review assumes the approach of the American Academy of Sleep Medicine, which claims that CRSDs can generate insomnia.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0063" ref-type="bibr">63</xref></citation_analysis><citation_analysis attribute="neither"> Nevertheless, thorough differential diagnosis between CRSDs and primary insomnia is necessary in order to apply proper treatment.</citation_analysis></p>
        <p><citation_analysis attribute="positive">The pathophysiology of CRSDs is complex. Research has demonstrated that polymorphisms in clock genes like </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">PER3</italic></citation_analysis><citation_analysis attribute="neither"> or </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">CLOCK</italic></citation_analysis><citation_analysis attribute="neither"> might contribute to a susceptibility to sleep disorders.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0064" ref-type="bibr">64–66</xref></citation_analysis><citation_analysis attribute="neither"> External factors appear to play a role as well, such as with shift-work sleep disorder.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0067" ref-type="bibr">67</xref></citation_analysis><citation_analysis attribute="neither"> Due to its interactions with the circadian rhythm, BDNF might partake in the pathophysiology of CRSDs; however, the literature on this subject remains limited. It has been evidenced, that this neurotrophin and its receptor TrkB are expressed in the SCN.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0068" ref-type="bibr">68</xref></citation_analysis><citation_analysis attribute="neither"> As for BDNF, D’Agostino et al showed that it could be indispensable in the maintenance of circadian oscillators: </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">BDNF</italic></citation_analysis><citation_analysis attribute="neither">-knockout zebrafish showed severe impairments in clock gene expression.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0069" ref-type="bibr">69</xref></citation_analysis><citation_analysis attribute="positive"> Studies demonstrate that this neurotrophin displays circadian rhythmicity. Piccini et al and Choi et al observed this relationship only in men.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0070" ref-type="bibr">70–72</xref></citation_analysis><citation_analysis attribute="neither"> However, in a study by Cain et al, as many as three in four women and one in two men had BDNF circadian rhythmicity.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0070" ref-type="bibr">70</xref></citation_analysis><citation_analysis attribute="neither"> The BDNF peal was unrelated to clock time in women, as opposed to men.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0070" ref-type="bibr">70</xref></citation_analysis><citation_analysis attribute="neither"> In a study on healthy male volunteers, Begliuomini et al showed that plasma levels of BDNF and cortisol are positively correlated and peak early in the day to later decrease.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0073" ref-type="bibr">73</xref></citation_analysis></p>
        <p><citation_analysis attribute="neither">Melatonin is a hormone produced in the pineal gland modulating the adjustment of circadian rhythm to the photoperiod. Jang et al showed that the melatonin precursor </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">N</italic></citation_analysis><citation_analysis attribute="neither">-acetylserotonin might activate TrkB receptors in a circadian-dependent manner, with peaks during the biological night.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0063" ref-type="bibr">63</xref></citation_analysis><citation_analysis attribute="positive"> This indolamine was shown to increase BDNF expression in animal models.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0074" ref-type="bibr">74</xref></citation_analysis><citation_analysis attribute="neither"> Nevertheless, a recent meta-analysis did not confirm the same effect in humans.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0075" ref-type="bibr">75</xref></citation_analysis><citation_analysis attribute="neither"> Future research on the subjects of interplay between the circadian rhythm, melatonin, and BDNF would be desirable. Organic and functional aspects of changes in the circadian rhythm occurring in the course of various CRSDs might be further studied in the context of BDNF and other neurotrophins.</citation_analysis></p>
      </sec>
    </sec>
    <sec id="s0003">
      <title>BDNF and Stress</title>
      <p><citation_analysis attribute="positive">Stress can exert various effects on health, depending on its predictability, intensity, and duration. The importance of stress-induced hyperarousal (in emotional–cognitive and somatic aspects) has long been suggested to play a role in the pathophysiology of insomnia.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0012" ref-type="bibr">12</xref></citation_analysis><citation_analysis attribute="positive"> It could be hypothesized that coping strategies (cognitive and behavioral) and sleep reactivity affect the risk of developing insomnia. Studies seem to confirm this. Otsuka et al demonstrated that insomnia is more prevalent in individuals with maladaptive behavioral patterns (ie, substance use, self-blame).</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0076" ref-type="bibr">76</xref></citation_analysis><citation_analysis attribute="neither"> Other researchers obtained similar results.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0077" ref-type="bibr">77</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0078" ref-type="bibr">78</xref></citation_analysis><citation_analysis attribute="neither"> Insomnia is also an important diagnostic symptom in anxiety disorders: approximately 70%–90% of these patients suffers from this sleep disorder.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0079" ref-type="bibr">79</xref></citation_analysis><citation_analysis attribute="negative"> As Neckelmann et al found, insomnia might also be a risk factor for anxiety disorder (OR 4.9, 95% CI 3.8–6.4).</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0080" ref-type="bibr">80</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">This system of sleep regulation might be disrupted by hyperarousal, an element strongly emphasized by insomnia models proposed in recent decades. Acute stress, a usual trigger of insomnia, was related to the increased activation of both sleep- and wake-promoting neurons, which under physiological conditions should be switched off.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0081" ref-type="bibr">81</xref></citation_analysis><citation_analysis attribute="neither"> The state of hyperarousal is difficult to exhaustively define: it might involve numerous components, like neurotransmitters, the endocrine system, and genetics.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0082" ref-type="bibr">82</xref></citation_analysis><citation_analysis attribute="neither"> Riemann et al in their work adopted a holistic view of this state, describing it as affecting cognitive–emotional, cortical, and physiological domains of functioning.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0083" ref-type="bibr">83</xref></citation_analysis><citation_analysis attribute="neither"> Even in the early studies, it was observed that insomnia individuals tend to display signs of enhanced metabolism, like increased body temperature, level of adrenaline, cortisol, and heart rate.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0082" ref-type="bibr">82</xref></citation_analysis><citation_analysis attribute="neither"> Hyperarousal in chronic insomnia might also be associated with secondary maladaptive behaviors developed in response to acute insomnia caused by a stressful life event.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0083" ref-type="bibr">83</xref></citation_analysis><citation_analysis attribute="positive"> These include rumination about adverse effects of currently experienced sleep disorder, focus on daytime insomnia symptoms, and drug/alcohol abuse, which further perpetuate the sleep disorder, creating a vicious circle.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0083" ref-type="bibr">83</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">Glucocorticoids can cross the blood–brain barrier and fulfill important functions within the central nervous system.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0084" ref-type="bibr">84</xref></citation_analysis><citation_analysis attribute="neither"> Under physiological conditions, they participate in the formation and stabilization of new synapses, as well as synaptic pruning.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0085" ref-type="bibr">85</xref></citation_analysis><citation_analysis attribute="neither"> Pathological excess of glucocorticoids, like in Cushing’s disease, is well known to have psychiatric consequences, such as mood disorders.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0086" ref-type="bibr">86</xref></citation_analysis><citation_analysis attribute="neither"> Individuals afflicted with this disease might also experience regressive changes in the hippocampus and the prefrontal cortex, eg, loss of synaptic density or dendrite arborization.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0086" ref-type="bibr">86</xref></citation_analysis><citation_analysis attribute="positive"> According to a recent meta-analysis, patients with insomnia also tend to have an increased level of peripheral cortisol as well as disturbed rhythm of secretion of this protein (ie, normal morning cortisol, increased during daytime and before bedtime), which demonstrated dysregulation of the HPA axis in this group.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0087" ref-type="bibr">87</xref></citation_analysis><citation_analysis attribute="positive"> Products of the HPA axis were demonstrated to alter BDNF production and pathway, which might suggest that their negative effects on neurons could be mediated by changes in activity of this neurotrophin.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0084" ref-type="bibr">84</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0088" ref-type="bibr">88–90</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">In a study on rats subjected to chronic stress, an increase in hippocampal, hypothalamic, and pituitary BDNF as well as plasmatic corticosterone in comparison with healthy controls was noted. Other studies with similar stress protocols showed that </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">BDNF</italic></citation_analysis><citation_analysis attribute="neither"> mRNA level was decreased in the hippocampal region.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0091" ref-type="bibr">91</xref></citation_analysis><citation_analysis attribute="neither"> Those results suggest that alterations in BDNF production are posttranscriptional; however, none of the BDNF precursor forms was measured.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0091" ref-type="bibr">91</xref></citation_analysis><citation_analysis attribute="positive"> The authors suggested that such alterations might aid in adaptive processes of the HPA axis due to BDNF’s role in synaptic plasticity.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0091" ref-type="bibr">91</xref></citation_analysis><citation_analysis attribute="neither"> This neurotrophin could also participate in restoration of cortisol reserves, depleted during stress.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0091" ref-type="bibr">91</xref></citation_analysis><citation_analysis attribute="positive"> What is interesting is that a pattern of time-dependent changes in BDNF levels in the pituitary and hypothalamus in response to an acute stressor were similar in the study group and controls; however, in the hippocampus, an opposite dynamic was observed, with significant decreases in the study group.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0091" ref-type="bibr">91</xref></citation_analysis><citation_analysis attribute="neither"> Such an effect could explain atrophy of C3 neurons, observed in chronic stress.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0091" ref-type="bibr">91</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">In a study on suicide attempters, those who had a dysregulated HPA axis (ie, did not experience suppression of cortisol production in the dexamethasone suppression test) showed a negative correlation between posttest cortisol level and plasma BDNF.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0092" ref-type="bibr">92</xref></citation_analysis><citation_analysis attribute="neither"> This association was present only in women, which might to some extend elucidate the mechanisms behind differences in suicidal behavior between sexes.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0092" ref-type="bibr">92</xref></citation_analysis><citation_analysis attribute="positive"> On the other hand, in a study on subjects with burnout, a psychosomatic disorder thought to stem from working in a high-stress environment, no significant relationship between BDNF and cortisol was noted.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0093" ref-type="bibr">93</xref></citation_analysis></p>
      <p><citation_analysis attribute="positive">Another subject worth mentioning in the context of interactions between BDNF and stress is anxiety disorders. There are reports of associations between the Val66Met polymorphism in the </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">BDNF</italic></citation_analysis><citation_analysis attribute="neither"> gene and the conditions discussed herein; however, studies on the subject have brought conflicting results.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0094" ref-type="bibr">94</xref></citation_analysis><citation_analysis attribute="neither"> According to a meta-analysis by Suliman et al, the level of this neurotrophin on the periphery is reduced in this group of patients, but this decrease is not uniform across the spectrum of anxiety disorders. Obsessive–compulsive disorder appeared to be responsible for BDNF reduction.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0094" ref-type="bibr">94</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">Next to catecholaminergic neurons and glucocorticoid axes, dopaminergic neurons are an important element of stress response.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0095" ref-type="bibr">95</xref></citation_analysis><citation_analysis attribute="neither"> The two important neuronal circuits that participate in adaptation to stress are the mesolimbic (reward) and corticolimbic (emotion) system. A10 dopamine-containing neurons are located in the ventral tegmental area (VTA), a part of the mesolimbic system that is responsible for reward, motivation, and executive and affective functions.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0095" ref-type="bibr">95</xref></citation_analysis><citation_analysis attribute="positive">
</citation_analysis><citation_analysis attribute="positive"><bold>Dopaminergic neurons from the VA project, among others, to the prefrontal cortex (PFC), amygdala, and nucleus accumbens (Nac)</bold></citation_analysis><citation_analysis attribute="neither">.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0088" ref-type="bibr">88</xref></citation_analysis><citation_analysis attribute="neither"> The mesolimbic system is connected to the corticolimbic system in numerous locations, like the PFC, the hippocampus, the VTA, and the Nac, and is considered to be the major interface between the limbic system and motor regions of the cortex.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0088" ref-type="bibr">88</xref></citation_analysis><citation_analysis attribute="neither"> Proper functioning and synchrony between these two systems allows for value-based learning and selection of action based on predicted consequences.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0088" ref-type="bibr">88</xref></citation_analysis><citation_analysis attribute="neither"> Impairments of the mesocorticolimbic system have been linked to drug abuse, addiction, and depression.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0088" ref-type="bibr">88</xref></citation_analysis><citation_analysis attribute="negative"> The relationship between substance abuse and sleep disorders might be a particularly interesting subject for future research, as it appears to have a bidirectional character: sleep complaints are among the most common in subjects who have a history of addiction, and patients with sleep disorders are at a high risk of developing problems with drugs or alcohol, as they try to self-medicate insomnia.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0096" ref-type="bibr">96</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">Based on studies on human brains and animal models, it appears that BDNF/TrkB expression is decreased in the corticolimbic system, inhibiting BDNF-mediated neuroplasticity in this region; the opposite occurs in the mesolimbic system.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0088" ref-type="bibr">88</xref></citation_analysis><citation_analysis attribute="neither"> Those alterations might increase the neuronal plasticity in the mesolimbic region, rendering individuals more prone to social stress or substance addiction.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0088" ref-type="bibr">88</xref></citation_analysis><citation_analysis attribute="neither"> It could be suspected that alterations in the BDNF signaling seen in insomnia could impair proper adaptive response to stress and instead facilitate the development of maladaptive habits, which would further exacerbate already existing problems with sleep, creating a vicious circle. The relationship between stress, BDNF signaling, and insomnia needs to be perceived as mutual. Disruption in one of those elements, caused by eg, trauma, could precipitate impairment of the others.</citation_analysis></p>
      <sec id="s0003-s2001">
        <title>BDNF and Sleep Deficiency</title>
        <p><citation_analysis attribute="positive">Sleep deficiency might have either a chronic or acute character, which seem to have opposed effects on the organism. It might be conceptualized as a disorder in its own right, as it accompanies a vast number of conditions. Studies conducted up to this point on the subject of changes in peripheral BDNF level in insomnia consistently show BDNF reduction in individuals afflicted with this sleep disorder, regardless of sex or accompanying psychiatric conditions; findings are summarized in </citation_analysis><citation_analysis attribute="positive"><xref rid="t0001" ref-type="table">Table 1</xref></citation_analysis><citation_analysis attribute="neither">.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0016" ref-type="bibr">16</xref></citation_analysis><citation_analysis attribute="neither"> Among all characteristics of insomnia, ie, troubles falling asleep or maintaining this state, early-morning awakenings, etc., BDNF might be the most related to short sleep duration. According to Furihata, there were no differences between individuals with normal sleep duration (above 6 hours), regardless of the presence of insomnia.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0097" ref-type="bibr">97</xref></citation_analysis><citation_analysis attribute="neither"> However, in a group with short (&lt;6 hours) sleep duration, BDNF levels were significantly lower only in subjects with insomnia.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0097" ref-type="bibr">97</xref></citation_analysis><citation_analysis attribute="neither"> In a study by Giese et al, BDNF concentration was negatively correlated with the severity of insomnia symptoms, as measured with the insomnia severity index (a scale based on DSM-IV criteria) and fatigue.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0098" ref-type="bibr">98</xref></citation_analysis><citation_analysis attribute="neither"> Moreover, in their study there were no differences in BDNF concentration between individuals diagnosed with RLS/periodic leg movements during sleep and those without.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0098" ref-type="bibr">98</xref></citation_analysis><citation_analysis attribute="neither"> RLS medication (ropinirole, antidepressants, etc.) did not affect the level of neurotrophin, which suggests that sleep disorders other than insomnia might not impact BDNF production.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0098" ref-type="bibr">98</xref></citation_analysis><citation_analysis attribute="negative"> There could be some variability depending on the biological material used in the study, ie, serum or plasma. About 99% of circulating BDNF is accumulated in platelets, which release it during coagulation.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0099" ref-type="bibr">99</xref></citation_analysis><citation_analysis attribute="neither"> Thus, in terms of serum, clotting time is crucial to results.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0099" ref-type="bibr">99</xref></citation_analysis><citation_analysis attribute="neither"> Trajkovska et al observed a decrease in serum BDNF in probes stored &gt;6 months.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0100" ref-type="bibr">100</xref></citation_analysis><citation_analysis attribute="neither"> BDNF concentration might also differ on an individual basis, depending on sex, age, or physical activity.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0099" ref-type="bibr">99</xref></citation_analysis><citation_analysis attribute="neither"> In subjects with insomnia and short sleep duration (&lt;6 hours), serum level of BDNF was positively correlated with neuropsychological faculties measured with tests on spatial span and brief visuospatial memory and the identical pair test.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0101" ref-type="bibr">101</xref></citation_analysis><citation_analysis attribute="positive">
</citation_analysis><citation_analysis attribute="positive"><table-wrap position="float" id="t0001"><label>Table 1</label><caption><p><citation_analysis attribute="positive">Summary of findings of studies on the subject of BDNF in insomnia</citation_analysis></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">No.</th><th align="center" rowspan="1" colspan="1">Authors, year</th><th align="center" rowspan="1" colspan="1">Study population, insomnia definition</th><th rowspan="1" colspan="1">Biomaterial</th><th align="center" rowspan="1" colspan="1">Findings</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">1.</td><td rowspan="1" colspan="1">Sanchez-Garcia et al 2023<xref rid="cit0102" ref-type="bibr">102</xref></td><td rowspan="1" colspan="1">Twenty-one insomnia patients and 22 healthy controls. Insomnia was defined as scoring at least 6 points on the AIS questionnaire.</td><td rowspan="1" colspan="1">Serum</td><td rowspan="1" colspan="1">Participants with insomnia showed decreased BDNF serum levels; BDNF serum level was negatively correlated with insomnia severity.</td></tr><tr><td rowspan="1" colspan="1">2.</td><td rowspan="1" colspan="1">Satyanarayanan et al 2020<xref rid="cit0103" ref-type="bibr">103</xref></td><td rowspan="1" colspan="1">Sixteen patients diagnosed with primary insomnia and 10 healthy controls. Criteria for insomnia diagnosis were not included in the manuscript.</td><td rowspan="1" colspan="1">Plasma</td><td rowspan="1" colspan="1">Levels of plasma BDNF protein were lower in subjects with insomnia compared to the controls.</td></tr><tr><td rowspan="1" colspan="1">3.</td><td rowspan="1" colspan="1">Zhang et al 2020<xref rid="cit0104" ref-type="bibr">104</xref></td><td rowspan="1" colspan="1">Twenty-seven patients with chronic insomnia disorder and 10 healthy controls. Insomnia was diagnosed according to ICSD-3 criteria.</td><td rowspan="1" colspan="1">Serum</td><td rowspan="1" colspan="1">Patients with insomnia exhibited lower serum BDNF levels than healthy controls.</td></tr><tr><td rowspan="1" colspan="1">4.</td><td rowspan="1" colspan="1">Furihata et al 2019<xref rid="cit0097" ref-type="bibr">97</xref></td><td rowspan="1" colspan="1">Five-hundred and seventy-seven female nurses: 123 reported insomnia, 72 insomnia with short sleep duration. Sleep was assessed with a self-reported questionnaire based on DSM-IV criteria for insomnia, which included questions about sleep duration, difficulty initiating sleep (DIS), difficulty maintaining, sleep (DMS), early-morning awakening (EMA), and sleep duration. Insomnia with short sleep duration was defined as: DIS, or DMS, or EMA; and &lt;6 hours sleep duration.</td><td rowspan="1" colspan="1">Serum</td><td rowspan="1" colspan="1">There were no differences in serum BDNF protein between participants with normal sleep time (at least 6 hours/night), regardless of the presence of insomnia. In participants with short sleep duration (&lt;6 hours/night), those with insomnia showed decreased BDNF serum levels compared to counterparts without sleep problems.</td></tr><tr><td rowspan="1" colspan="1">5.</td><td rowspan="1" colspan="1">Fan et al 2019<xref rid="cit0101" ref-type="bibr">101</xref></td><td rowspan="1" colspan="1">Fifty-seven patients with insomnia (30 with sleep duration &lt;6 hours/night, 27 with normal sleep duration), and 29 healthy controls. Insomnia diagnosis was made according to DSM-V criteria.</td><td rowspan="1" colspan="1">Serum</td><td rowspan="1" colspan="1">Participants with insomnia with short sleep duration but not normal sleep duration had a lower serum BDNF protein level compared to healthy controls. In a within-group analysis, participants with insomnia with short sleep duration also exhibited a lower serum BDNF level than those with normal sleep duration.</td></tr><tr><td rowspan="1" colspan="1">6.</td><td rowspan="1" colspan="1">Mikoteit et al 2019<xref rid="cit0105" ref-type="bibr">105</xref></td><td rowspan="1" colspan="1">Sixty patients with insomnia and 30 healthy controls. Insomnia was assessed with the ISI questionnaire, based on DSM-IV diagnostic criteria for insomnia.</td><td rowspan="1" colspan="1">Serum</td><td rowspan="1" colspan="1">Serum BDNF was decreased in the insomnia group compared to controls. Insomnia severity was predictive of lower BDNF levels.</td></tr><tr><td rowspan="1" colspan="1">7.</td><td rowspan="1" colspan="1">Deuschle et al 2018<xref rid="cit0106" ref-type="bibr">106</xref></td><td rowspan="1" colspan="1">Thirty-five patients with insomnia and 37 healthy controls. Insomnia diagnosis was made according to the ICSD-2 criteria.</td><td rowspan="1" colspan="1">Serum</td><td rowspan="1" colspan="1">BDNF serum levels did not differ between subjects with insomnia and healthy controls.</td></tr><tr><td rowspan="1" colspan="1">8.</td><td rowspan="1" colspan="1">Giese et al 2014<xref rid="cit0098" ref-type="bibr">98</xref></td><td rowspan="1" colspan="1">Twenty-six insomnia patients (including 19 with restless leg syndrome/periodic limb movement) and 24 healthy controls. Insomnia was defined as scoring more than 8 points on the ISI questionnaire based on the DSM-IV diagnostic criteria for insomnia.</td><td rowspan="1" colspan="1">Serum</td><td rowspan="1" colspan="1">Insomnia was associated with lower serum BDNF levels compared with healthy controls. Serum BDNF concentration was negatively correlated with insomnia severity as assessed by ISI.</td></tr></tbody></table><table-wrap-foot><fn id="tfn0001"><p><citation_analysis attribute="positive"><bold>Abbreviations</bold></citation_analysis><citation_analysis attribute="neither">: AIS, Athens Insomnia Scale; DSM, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">Diagnostic And Statistical Manual of Mental Disorders</italic></citation_analysis><citation_analysis attribute="neither">; ICSD, International Classification of Sleep Disorders, ISI, Insomnia Severity Index.</citation_analysis></p></fn></table-wrap-foot></table-wrap></citation_analysis></p>
        <p><citation_analysis attribute="neither">Acute sleep deficiency, ie, sleep deprivation, might increase BDNF both systemically in plasma/serum and locally in certain brain regions, eg, in the hippocampus.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0020" ref-type="bibr">20</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0107" ref-type="bibr">107</xref></citation_analysis><citation_analysis attribute="negative"> It appears to be more related to lack of NREM sleep, as isolated REM sleep deprivation in general does not seem to strongly affect production of this neurotrophin.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0107" ref-type="bibr">107</xref></citation_analysis><citation_analysis attribute="neither"> However, there are studies showing elevated BDNF in the brain stem following REM sleep deprivation.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0020" ref-type="bibr">20</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0108" ref-type="bibr">108</xref></citation_analysis></p>
        <p><citation_analysis attribute="positive">A causal relationship between different types of sleep deficiency and BDNF used to be explained in the context of the biphasic model of stress, which is tightly connected to glutamate signaling in the prefrontal cortex.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0109" ref-type="bibr">109</xref></citation_analysis><citation_analysis attribute="neither"> Namely, acute stress (ie, sleep deprivation) enhances glutamatergic signaling in the PFC.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0109" ref-type="bibr">109</xref></citation_analysis><citation_analysis attribute="neither"> This process takes place thanks to genomic and nongenomic mechanisms, triggered by activation of the MR–GR pathway by corticosterone.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0109" ref-type="bibr">109</xref></citation_analysis><citation_analysis attribute="neither"> Intensification of glutamatergic transmission might promote further adaptive changes in function, morphology, and number of synapses, promoting working memory and adaptation.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0109" ref-type="bibr">109</xref></citation_analysis><citation_analysis attribute="neither"> Long-term stress (ie, insomnia) has opposite effects, producing reduction of dendritic complexity and atrophy, which might ultimately severely impair behavior.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0109" ref-type="bibr">109</xref></citation_analysis></p>
        <p><citation_analysis attribute="positive">Nevertheless, this model does not fully answer the question of why chronic sleep deficiency actually leads to BDNF depletion. As shown in </citation_analysis><citation_analysis attribute="positive"><xref rid="f0001" ref-type="fig">Figure 1</xref></citation_analysis><citation_analysis attribute="positive">, BDNF, due to a positive autoregulatory feedback loop is able to stimulate its own transcription in a CREB-mediated mechanism, as well as TrkB surface expression. Additionally, TrkB might be transactivated from adrenergic, dopaminergic or glucocorticoid activity in a manner similar to that caused by neurotrophins.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0016" ref-type="bibr">16</xref></citation_analysis><citation_analysis attribute="neither"> Interestingly, it appears that prolonged BDNF exposure might actually lead to a decrease in TrkB expression on the cell surface, leading to desensitization, which could ultimately reduce BDNF production.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0110" ref-type="bibr">110</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0111" ref-type="bibr">111</xref></citation_analysis><citation_analysis attribute="neither"> Further studies on the BDNF pathway in insomnia would be desirable to elucidate the time point as well as exact mechanism of BDNF depletion in this sleep disorder.
</citation_analysis><citation_analysis attribute="positive"><fig position="float" id="f0001" fig-type="figure"><label>Figure 1</label><caption><p><citation_analysis attribute="neither">The possible mechanism of interactions between sleep deficiency and BDNF.</citation_analysis></p></caption><graphic xlink:href="NSS-15-1045-g0001" content-type="print-only" position="float"/><attrib><bold>Notes</bold>: Acute sleep deficiency induces BDNF production that might promote glutamatergic signaling in the PFC, improving adaptation to a new stressor. Overtime, increased exposure to BDNF leads to desensitization and insufficiency of positive autoregulatory feedback loops, ie, decreased expression of TrkB and CREB pathway activity, which fails to maintain adequate levels of this neurotrophin.</attrib><attrib><bold>Abbreviations</bold>: BDNF, brain-derived neurotrophic factor; CREB, cAMP response element-binding protein; prefrontal cortex, PFC; tropomyosin receptor kinase B, TrkB.</attrib></fig></citation_analysis></p>
        <p><citation_analysis attribute="positive">BDNF is primarily produced by neurons; however, studies have shown that it can also be released by astrocytes and microglia. Zhang et al found that insomnia was associated with increased serum level of S100B, GFAP, BDNF, and GDNF, which could suggest astrocyte dysfunction.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0104" ref-type="bibr">104</xref></citation_analysis><citation_analysis attribute="positive"> In another study, both short sleep deprivation and chronic sleep restriction were shown to increase the rate of astrocytic phagocytosis involving presynaptic parts of larger synapses.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0112" ref-type="bibr">112</xref></citation_analysis><citation_analysis attribute="neither"> The pattern of changes in lipid peroxidation in synaptoneurosomes and the expression of </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">MERTK</italic></citation_analysis><citation_analysis attribute="neither">, the gene responsible for astrocytic phagocytosis, was also similar, and thus authors concluded this was a cleaning of overused synaptic components during wake time.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0112" ref-type="bibr">112</xref></citation_analysis><citation_analysis attribute="neither"> However, in contrast to SD, chronic sleep restriction was associated with microglial activation and phagocytosis without other overt signs of neuroinflammation.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0112" ref-type="bibr">112</xref></citation_analysis><citation_analysis attribute="neither"> Such low-level, long-term microglial activation (microglial priming) could be associated with pathologically enhanced response to other insults, thus being detrimental to the brain.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0112" ref-type="bibr">112</xref></citation_analysis><citation_analysis attribute="positive"> Those results show that alterations in morphology and functioning of glial cells might be relevant to the pathophysiology of insomnia, and further studies on this subject would be highly desirable.</citation_analysis></p>
        <p><citation_analysis attribute="neither">Obstructive sleep apnea (OSA) is a common disorder characterized by recurrent collapse of the upper airways during sleep, causing intermittent hypoxia.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0099" ref-type="bibr">99</xref></citation_analysis><citation_analysis attribute="positive"> This condition is associated with sleep fragmentation caused by frequent subconscious awakenings, which could be considered a form of sleep deficiency. BDNF has been quite extensively studied in the context of OSA, primarily due to its connections with cognitive decline.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0099" ref-type="bibr">99</xref></citation_analysis><citation_analysis attribute="neither"> Studies conducted to date are heterogeneous.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0099" ref-type="bibr">99</xref></citation_analysis><citation_analysis attribute="positive"> A recent meta-analysis demonstrated that peripheral levels of BDNF are unaltered by OSA or its standard treatment—continuous positive airway pressure therapy.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0113" ref-type="bibr">113</xref></citation_analysis></p>
      </sec>
    </sec>
    <sec id="s0004">
      <title>Molecular Basis of Insomnia</title>
      <p><citation_analysis attribute="neither">Insomnia is a disorder with a complex background, involving interactions between psychological and somatic aspects of health. It frequently overlaps with disrupted BDNF production, as is the case in depression or obsessive–compulsive disorder.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0094" ref-type="bibr">94</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0114" ref-type="bibr">114</xref></citation_analysis><citation_analysis attribute="positive"> Several systems have been implicated in the pathophysiology of insomnia, one of them being GABA signaling. Besides having a major role in sleep initiation and maintenance, it is also a target for insomnia medications (ie, benzodiazepines), which increase the affinity of GABA receptors.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0115" ref-type="bibr">115</xref></citation_analysis><citation_analysis attribute="neither"> According to a study by Morgan et al, individuals with primary insomnia tend to have increased levels of this neurotransmitter in the occipital region, as measured by proton magnetic resonance spectroscopy (1H-MRS); moreover, GABA was negatively correlated with a polysomnographic parameter—wake after sleep onset.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0116" ref-type="bibr">116</xref></citation_analysis><citation_analysis attribute="positive"> The authors explained this as an allogenic response to hyperarousal.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0116" ref-type="bibr">116</xref></citation_analysis><citation_analysis attribute="neither"> However, Plante et al obtained opposite results, showing stark reductions of GABA in the brain.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0115" ref-type="bibr">115</xref></citation_analysis><citation_analysis attribute="positive"> Discrepancies between studies could be attributed to, among others, timing of data acquisition, differences in sleep quality between respective control groups, as well as method of objective sleep assessment (polysomnography or actigraphy).</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0115" ref-type="bibr">115</xref></citation_analysis><citation_analysis attribute="positive"> Oral administration of GABA might show benefits related to early stages of sleep, ie, increased duration of the first NREM, and decreased sleep latency, but they might be related to its stress-relieving effects.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0117" ref-type="bibr">117</xref></citation_analysis><citation_analysis attribute="neither"> Glutamatergic neurotransmission is tightly connected to GABA. Glutamate is an excitatory neurotransmitter, which might be converted into GABA by glutamate decarboxylase 1, thus supplying inhibitory synapses.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0118" ref-type="bibr">118</xref></citation_analysis><citation_analysis attribute="neither"> L-glutamate in atoxic concentrations might be also found extrasynaptically in the area surrounding neurons.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0119" ref-type="bibr">119</xref></citation_analysis><citation_analysis attribute="neither"> The relationship between insomnia and glutamatergic transmission is still under investigation. It appears to be of special importance in neurodegenerative disorders, which are linked to glutamate excitotoxicity.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0120" ref-type="bibr">120</xref></citation_analysis><citation_analysis attribute="neither"> Glutamate signaling has a major role in regulation of circadian rhythm by regulating the functioning of the SCN, the central master clock.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0121" ref-type="bibr">121</xref></citation_analysis><citation_analysis attribute="neither"> A majority of neurons in this structure are GABAergic; GABA release might be promoted by astrocytic glutamate via activation of the NR2C subunit of the glutamate NMDAR, which inhibits activation of postsynaptic neurons.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0121" ref-type="bibr">121</xref></citation_analysis><citation_analysis attribute="negative"> Selective NR2C blockade impairs the circadian variability of neuronal membrane potential as well as expression of clock genes.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0121" ref-type="bibr">121</xref></citation_analysis><citation_analysis attribute="neither"> Glutamate has two main transporters that regulate its working concentration in the brain: vesicular glutamate transporters (VGLUTs) and excitatory amino acid transporters (EAATs).</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0121" ref-type="bibr">121</xref></citation_analysis><citation_analysis attribute="neither"> In animal models, alteration of EAAT1 expression changed the sleep phenotype in </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">Drosophila</italic></citation_analysis><citation_analysis attribute="neither">, whereas injection of glutamate into SCN induced phase shifts.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0121" ref-type="bibr">121</xref></citation_analysis><citation_analysis attribute="neither"> Such disruptions might negatively affect the functioning of the Zeitgeber and contribute to the development of sleep disruptions associated with impaired circadian rhythm.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0121" ref-type="bibr">121</xref></citation_analysis><citation_analysis attribute="positive"> Models involving sleep deprivation give further insight into the link between sleep and mode of neurotransmission. Sleep deprivation in mice was demonstrated to increase the expression of GLT1, which removes excessive glutamate.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0121" ref-type="bibr">121</xref></citation_analysis><citation_analysis attribute="neither"> Rats subjected to this form of sleep deficiency had a higher concentration of extrasynaptic glutamate.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0121" ref-type="bibr">121</xref></citation_analysis><citation_analysis attribute="positive"> Increase in BDNF following acute sleep deprivation might be of importance here, as it was shown to protect neurons against excitotoxicity and oxidative damage.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0017" ref-type="bibr">17</xref></citation_analysis><citation_analysis attribute="neither"> Interestingly, in a study on mice subjected to chronic sleep restriction, the study group sustained less damage following the injection of NMDA (NMDAR agonist used to mimic the actions of glutamate) to the nucleus basalis magnocellularis.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0122" ref-type="bibr">122</xref></citation_analysis><citation_analysis attribute="positive"> Thus, it appears that there are mechanisms protecting the central nervous system from the damage inflicted by deregulation of the glutamatergic system associated with different forms of sleep deficiency, but this subject remains underinvestigated. More studies are validated to broaden the knowledge on the topic of interactions between glutamatergic signaling and insomnia.</citation_analysis></p>
      <p><citation_analysis attribute="neither">Histamine is also considered to be an important neurotransmitter in the pathophysiology of insomnia. In the brain, it is produced only by the tuberomamillary nucleus (TMN); it acts as an REM suppressant and promotes wakefulness.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0118" ref-type="bibr">118</xref></citation_analysis><citation_analysis attribute="neither"> It has three main receptors: stimulatory H1, H2, and inhibitory H3. H1 and H3 appear to be of the most relevance for sleep. H1 antagonists (or rather inverse agonists, reducing the activity of constitutively active receptors) are known to cause sleepiness, such as diphenhydramine.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0118" ref-type="bibr">118</xref></citation_analysis><citation_analysis attribute="neither"> Pharmacological inhibition of H1 in rats increased NREM; animals bereft of this receptor acted in a soporific way when compared to the control group.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0118" ref-type="bibr">118</xref></citation_analysis><citation_analysis attribute="positive"> Substances that disturb H3 signaling (ie, ciprofloxacin) were shown to suppress sleep in animal studies.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0118" ref-type="bibr">118</xref></citation_analysis><citation_analysis attribute="positive"> Interestingly, other studies on animals with impaired histaminergic signaling have demonstrated that such damage might be to some extent compensated by other arousal systems, but those mechanisms fail when a higher level of arousal is required, such as in high-stress environments.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0118" ref-type="bibr">118</xref></citation_analysis><citation_analysis attribute="positive"> Studies regarding regulation feeding behavior also bring interesting results. Gotoh et al have demonstrated that food intake might be modulated by interactions between BDNF, corticotropin-releasing factor and histamine.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0123" ref-type="bibr">123</xref></citation_analysis><citation_analysis attribute="neither"> Namely, BDNF in the ventromedial nucleus (VMH) regulates histamine production in the TMN via activation of corticotropin-releasing factor (CRF) neurons in the paraventricular nucleus (PVN).</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0123" ref-type="bibr">123</xref></citation_analysis><citation_analysis attribute="neither"> The released histamine in turn inhibits different groups of feeding neurons and BDNF neurons located in the VMH and PVN via the H1 receptor.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0123" ref-type="bibr">123</xref></citation_analysis><citation_analysis attribute="neither"> Weight gain caused by the use of second-generation antipsychotic drugs was also associated with BDNF concentration in the hypothalamus and on the periphery.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0124" ref-type="bibr">124</xref></citation_analysis><citation_analysis attribute="neither"> Similar studies appear to be needed on the subject of disruptions of sleep and circadian rhythm.</citation_analysis></p>
      <p><citation_analysis attribute="neither">Orexins are produced by neurons in the hypothalamic region.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0125" ref-type="bibr">125</xref></citation_analysis><citation_analysis attribute="neither"> They project to various locations in the brain that contain structures important for sleep regulation, such as the ventrolateral preoptic nucleus (VLPO), locus coeruleus (LC), and the TMN.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0125" ref-type="bibr">125</xref></citation_analysis><citation_analysis attribute="neither"> Orexin neurons control the release of histamine form the TMN neurons; notably, there is no feedback loop, as histamine does not influence orexin neurons.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0125" ref-type="bibr">125</xref></citation_analysis><citation_analysis attribute="neither"> Current medications targeting this mode of neurotransmission might be classified into two types: dual orexin receptor antagonist (DORA), antagonists of both orexin receptor type 1 (OX1R) and OX2R, which include relatively popular lemborexant and suvorexant, and selective orexin receptor antagonist (SORA), targeting only OX2R, such as seltorexant.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0125" ref-type="bibr">125</xref></citation_analysis><citation_analysis attribute="neither"> The latter group is still under development.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0125" ref-type="bibr">125</xref></citation_analysis><citation_analysis attribute="neither"> To date, studies report that they decrease sleep latency as well as wake after sleep onset, while increasing total sleep time.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0125" ref-type="bibr">125</xref></citation_analysis><citation_analysis attribute="positive"> Orexin might also promote BDNF production, thus exerting neuroprotective effects on neurons.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0044" ref-type="bibr">44</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">Saper et al have proposed a flip-flop switch model of sleep regulation, presenting a neuronal pathway consisting of sleep-promoting GABAergic neurons in the VLPO that cooperate with neuronal pathways promoting the wakeful state, namely the orexinergic neurons in the hypothalamus, noradrenergic LC, histaminergic TMN, serotonergic dorsal raphe nuclei (DRN) as well as cholinergic neurons in the pontine laterodorsal and pedunculopontine tegmental (LDT/PPT) nuclei.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0126" ref-type="bibr">126</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0127" ref-type="bibr">127</xref></citation_analysis><citation_analysis attribute="neither"> The ascending reticular system in the brain is also vital for cortical arousal.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0127" ref-type="bibr">127</xref></citation_analysis><citation_analysis attribute="neither"> Alternations between phases are controlled by the switch located in the thalamus.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0127" ref-type="bibr">127</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">Insomnia is currently regarded as a polygenic disorder.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0128" ref-type="bibr">128</xref></citation_analysis><citation_analysis attribute="positive"> Genome-wide analyses as well as twin studies show that insomnia shows significant heritability and an overlap with major depression, bipolar disorder as well as schizophrenia.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0128" ref-type="bibr">128–130</xref></citation_analysis><citation_analysis attribute="negative"> The risk of insomnia increases proportionally to the number of variants, which individually have little contribution to the final outcome.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0131" ref-type="bibr">131</xref></citation_analysis><citation_analysis attribute="neither"> Van Someren has proposed that genetic alterations conditioning enhanced activity of the salience network, a circuit consisting primarily of the dorsal anterior cingulate cortex and the anterior insula, might be associated with lower amounts of SWS due to increased propensity to arousal.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0131" ref-type="bibr">131</xref></citation_analysis><citation_analysis attribute="neither"> In his review, he also stressed the importance of disturbances in REM sleep, caused by noradrenaline input from the LC, to impaired stress adaptation, restoration and synaptic plasticity in the course of insomnia.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0131" ref-type="bibr">131</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">Studies have revealed that sleep–wake rhythm, sleep timing, etc. are regulated by genes responsible for stress response and circadian rhythm; specific genotypes described to date include variances of genes responsible for GABAergic signaling and clock genes, as well as polymorphism of a serotonin transporter promoter variant (5-HTTLPR), a potential mediator between stress and depression.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0132" ref-type="bibr">132</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0133" ref-type="bibr">133</xref></citation_analysis><citation_analysis attribute="neither"> Individuals homozygous for the Clock gene variant 3111C/C Clock tend to suffer from insomnia more frequently than healthy controls.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0130" ref-type="bibr">130</xref></citation_analysis><citation_analysis attribute="neither"> A missense mutation GABA-A β3 subunit might be associated with chronic insomnia.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0134" ref-type="bibr">134</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">Stress or trauma early in development has long been connected to sleep disorder; a possible mechanism behind this effect involves epigenetic regulations. In contrast to rather static genetic factors, they have a dynamic character and might alter in response to environmental cues, thus providing more insight into changes occurring in this sleep disorder.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0083" ref-type="bibr">83</xref></citation_analysis><citation_analysis attribute="positive"> Studies have demonstrated that stress in the prenatal period and early life development might have long-lasting consequences, increasing the reactivity of the HPA axis and impairing its negative feedback control.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0130" ref-type="bibr">130</xref></citation_analysis><citation_analysis attribute="neither"> Other studies on animals connect early-life stress to alterations in sleep architecture (eg, increased sleep fragmentation, decreasing deep SWS in relation to total sleep time).</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0130" ref-type="bibr">130</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0135" ref-type="bibr">135</xref></citation_analysis><citation_analysis attribute="neither"> Epigenetic regulation involves mechanisms like histone modification, regulatory noncoding RNA, as well as DNA methylation, which appears to be especially important to sleep disorders. Sammallahti et al have found that decreased methylation at cg24815001 in newborns was liked with longer sleep duration.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0136" ref-type="bibr">136</xref></citation_analysis><citation_analysis attribute="neither"> Similar change at cg02753354 resulted in longer sleep onset latency.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0136" ref-type="bibr">136</xref></citation_analysis><citation_analysis attribute="neither"> According to other studies, PPARA methylation in adolescent girls was inversely associated with sleep fragmentation.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0128" ref-type="bibr">128</xref></citation_analysis><citation_analysis attribute="neither"> Koopman-Verhoeff et al have identified that DNA methylation in the 17q21.31 region (which includes, among others, MAPT, a regulator of Tau proteins, involved in neuronal functioning) was associated with sleep duration.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0137" ref-type="bibr">137</xref></citation_analysis><citation_analysis attribute="positive"> Other authors also found associations between DNA methylation, sleep duration, and chronotype in children and adolescents.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0128" ref-type="bibr">128</xref></citation_analysis><citation_analysis attribute="neither"> Ancelin et al have revealed that four single-nucleotide polymorphisms in the </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">BDNF</italic></citation_analysis><citation_analysis attribute="neither"> gene as well as higher methylation of BDNF promoter I were connected to increased wake after sleep onset (WASO), a polysomnographic parameter frequently disrupted in insomnia as well as other sleep disorders.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0138" ref-type="bibr">138</xref></citation_analysis><citation_analysis attribute="neither"> Interestingly, such a relationship was not present in psychotropic drug users, suggesting their modifying effect on BDNF production.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0138" ref-type="bibr">138</xref></citation_analysis><citation_analysis attribute="negative"> Relationships between sleep and epigenetics might have a mutual character. Lahtinen et al in their study on adult individuals with subjective sleep deficiency revealed that they tend to have altered methylation of genes associated with nervous system development, mainly hypomethylation.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0139" ref-type="bibr">139</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">Sleep disturbances share a connection with neurodegenerative disorders. In a study by Elwood et al, severe excessive daytime sleepiness was a strong predictor of vascular dementia OR of 4.44 (95% CI 2.05–9.61).</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0140" ref-type="bibr">140</xref></citation_analysis><citation_analysis attribute="neither"> In cases of Lewy body dementia, sleep disturbances, such as REM behavior disorder (RBD), are estimated to occur in ca. 90% of patients.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0141" ref-type="bibr">141</xref></citation_analysis><citation_analysis attribute="neither"> Prevalence of sleep disorders in patients with AD, the most common type of dementia, varies from 14% to 69%.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0142" ref-type="bibr">142</xref></citation_analysis><citation_analysis attribute="neither"> Moreover, neurodegenerative processes are associated with disruptions in circadian rhythm: in AD subjects, autopsies revealed loss of neurons expressing vasopressin, vasoactive intestinal peptide (VIP), and melatonin receptor type 1 in the SCN.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0143" ref-type="bibr">143</xref></citation_analysis><citation_analysis attribute="neither"> Melatonin level might also be increasingly reduced in the course of AD.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0143" ref-type="bibr">143</xref></citation_analysis><citation_analysis attribute="neither"> Conversely, sleep loss can further exacerbate the course of the disease, increasing Aβ content and markers of neuroinflammation in the cerebrospinal fluid</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0143" ref-type="bibr">143</xref></citation_analysis><citation_analysis attribute="positive"> BDNF might also act as a link between neurodegeneration and chronic sleep deficiency. Studies have consistently shown decrease of this neurotrophin in both AD and insomnia patients. In this case, reduction of BDNF is induced by accumulation of Aβ and Tau. It is associated with apoptosis of neurons, due to lack of antiapoptotic stimulation, which in AD usually begins in the entorhinal cortex, spreading to hippocampus, amygdala and other structures (limbic system, neocortex) in a symmetrical fashion.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0144" ref-type="bibr">144</xref></citation_analysis><citation_analysis attribute="neither"> Similarly, in individuals with insomnia, hippocampal volume on magnetic resonance imaging (MRI) was reduced on both sides compared to their counterparts with no sleep problems.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0130" ref-type="bibr">130</xref></citation_analysis><citation_analysis attribute="neither"> Memory impairments, traditionally associated with insomnia, might be related to such findings; nevertheless, such studies were impossible to replicate.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0130" ref-type="bibr">130</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0145" ref-type="bibr">145</xref></citation_analysis><citation_analysis attribute="neither"> People with insomnia disorder also tend to display reduced gray matter in areas like the parietal, orbitofrontal and middle cingulate cortex.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0145" ref-type="bibr">145</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">The molecular background of insomnia is an interdisciplinary and active area of research. Studies on the subject of genetic overlap between this sleep disorder and other psychiatric or somatic diseases would be desirable. Projects comparing different insomnia phenotypes as well as their interactions with comorbidities would provide more insight into the pathophysiology of this sleep disorder.</citation_analysis></p>
    </sec>
    <sec id="s0005">
      <title>Conclusion and Future Prospects</title>
      <p><citation_analysis attribute="negative">Even after years of research, numerous aspects of relationships between BDNF and insomnia remain elusive. Current studies chart a few new fields for research. First, it would be interesting to further explore the relationship between sleep regulation, architecture, and BDNF, which could in the future allow for a more personalized management of sleep disorders, especially in patients administered medications that modify the production of this neurotrophin, such as antidepressants. This topic is related to CRSD. Sudying the role of BDNF in those conditions would facilitate better understanding of differences between sleep disorders related to circadian rhythm and primary insomnia. Advancements in this field would allow for development of targeted treatment protocols for those conditions. Interactions between BDNF and stress might be an interesting field for future research in the context of both epigenetic changes regarding DNA methylation in different sleep disturbances as well as individual traits predisposing to insomnia, such as neuroticism. Another interdisciplinary field is the subject of BDNF in substance abuse, as it might involve both neuropsychological predisposing factors, neurodegeneration, as well as imbalance in certain neuronal circuits, mesolimbic and mesocortical in particular.</citation_analysis></p>
      <p><citation_analysis attribute="positive">Expanding the knowledge about BDNF’s connections to other signaling pathways appears to be particularly important due to the ongoing search for better strategies in treatment of sleep disorders. Orexin is a particularly salient subject in this regard due to its potential antidepressant effect. It would also be of interest to gain insight into the interactions between different SORAs/DORAs and BDNF. Projects aiming to investigate the exact processes behind BDNF reduction in neurodegenerative diseases as well as potential compensational mechanisms observed in certain studies (ie, increase in peripheral BDNF) might be desirable. It would also be interesting in the context of searching early biomarkers for dementia. In a 2020 study by Cechova et al, proBDNF:BDNF ratio was a more reliable marker for cognitive performance than any of those proteins alone.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0146" ref-type="bibr">146</xref></citation_analysis><citation_analysis attribute="neither"> Another question is whether early diagnosis and proper treatment of sleep disturbances might delay the onset of dementia, decreasing the disease burden in society.</citation_analysis></p>
      <p><citation_analysis attribute="positive">The relationship between BDNF and insomnia is multifaceted. The titular neurotrophin might have a major influence on neurotransmitters like histamine, orexin, and GABA which regulate sleep and wakefulness. Due to its neuroprotective properties, it could be involved in the pathophysiology of neurodegenerative conditions, which are frequently accompanied by various sleep disorders. BDNF might also be implicated in formation of traits predisposing to insomnia, like neuroticism, as well as other epigenetic/genetic factors. Studies have also demonstrated its importance for circadian rhythm and sleep architecture. Broadening the knowledge on insomnia will certainly improve lives of patients afflicted with insomnia as well as aid in development of new molecular targets for treatment. The present review might aid in selecting research subjects as well as offer a new perspective on BDNF’s role in sleep medicine and adjacent fields.</citation_analysis></p>
    </sec>
  </body>
  <back>
    <sec sec-type="COI-statement" id="s0006">
      <title>Disclosure</title>
      <p><citation_analysis attribute="neither">The authors report no conflicts of interest in this work.</citation_analysis></p>
    </sec>
    <ref-list>
      <title>References</title>
      <ref id="cit0001">
        <label>1.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Ananthakrishnan</surname>
<given-names>AN</given-names></string-name>, <string-name><surname>Long</surname>
<given-names>MD</given-names></string-name>, <string-name><surname>Martin</surname>
<given-names>CF</given-names></string-name>, <string-name><surname>Sandler</surname>
<given-names>RS</given-names></string-name>, <string-name><surname>Kappelman</surname>
<given-names>MD</given-names></string-name>. <article-title>Sleep disturbance and risk of active disease in patients with Crohn’s disease and ulcerative colitis</article-title>. <source><italic toggle="yes">Clin Gastroenterol Hepatol</italic></source>. <year>2013</year>;<volume>11</volume>(<issue>8</issue>):<fpage>965</fpage>–<lpage>971</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cgh.2013.01.021</pub-id><pub-id pub-id-type="pmid">23376797</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0002">
        <label>2.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Seo</surname>
<given-names>HM</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>TL</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>JS</given-names></string-name>. <article-title>The risk of alopecia areata and other related autoimmune diseases in patients with sleep disorders: a Korean population-based retrospective cohort study</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2018</year>;<volume>41</volume>(<issue>9</issue>). doi:<pub-id pub-id-type="doi">10.1093/sleep/zsy111</pub-id></mixed-citation>
      </ref>
      <ref id="cit0003">
        <label>3.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Young</surname>
<given-names>KA</given-names></string-name>, <string-name><surname>Munroe</surname>
<given-names>ME</given-names></string-name>, <string-name><surname>Harley</surname>
<given-names>JB</given-names></string-name>, et al. <article-title>Less than 7 hours of sleep per night is associated with transitioning to systemic lupus erythematosus</article-title>. <source><italic toggle="yes">Lupus</italic></source>. <year>2018</year>;<volume>27</volume>(<issue>9</issue>):<fpage>1524</fpage>–<lpage>1531</lpage>. doi:<pub-id pub-id-type="doi">10.1177/0961203318778368</pub-id><pub-id pub-id-type="pmid">29804502</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0004">
        <label>4.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Sang</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Gao</surname>
<given-names>RC</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>MY</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>ZZ</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>ZG</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>GC</given-names></string-name>. <article-title>Causal relationship between sleep traits and risk of systemic lupus erythematosus: a two-sample Mendelian randomization study</article-title>. <source><italic toggle="yes">Front Immunol</italic></source>. <year>2022</year>;<volume>13</volume>:<fpage>918749</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fimmu.2022.918749</pub-id><pub-id pub-id-type="pmid">35784289</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0005">
        <label>5.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Serchov</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Clement</surname>
<given-names>HW</given-names></string-name>, <string-name><surname>Schwarz</surname>
<given-names>MK</given-names></string-name>, et al. <article-title>Increased signaling via adenosine A1 receptors, sleep deprivation, imipramine, and ketamine inhibit depressive-like behavior via induction of Homer1a</article-title>. <source><italic toggle="yes">Neuron</italic></source>. <year>2015</year>;<volume>87</volume>(<issue>3</issue>):<fpage>549</fpage>–<lpage>562</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuron.2015.07.010</pub-id><pub-id pub-id-type="pmid">26247862</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0006">
        <label>6.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Schutte-Rodin</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Broch</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Buysse</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Dorsey</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Sateia</surname>
<given-names>M</given-names></string-name>. <article-title>Clinical guideline for the evaluation and management of chronic insomnia in adults</article-title>. <source><italic toggle="yes">J Clin Sleep Med</italic></source>. <year>2008</year>;<volume>4</volume>(<issue>5</issue>):<fpage>487</fpage>–<lpage>504</lpage>. doi:<pub-id pub-id-type="doi">10.5664/jcsm.27286</pub-id><pub-id pub-id-type="pmid">18853708</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0007">
        <label>7.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Bhaskar</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Hemavathy</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Prasad</surname>
<given-names>S</given-names></string-name>. <article-title>Prevalence of chronic insomnia in adult patients and its correlation with medical comorbidities</article-title>. <source><italic toggle="yes">J Family Med Prim Care</italic></source>. <year>2016</year>;<volume>5</volume>(<issue>4</issue>):<fpage>780</fpage>–<lpage>784</lpage>. doi:<pub-id pub-id-type="doi">10.4103/2249-4863.201153</pub-id><pub-id pub-id-type="pmid">28348990</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0008">
        <label>8.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Ditmer</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Gabryelska</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Turkiewicz</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Bialasiewicz</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Malecka-Wojciesko</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Sochal</surname>
<given-names>M</given-names></string-name>. <article-title>Sleep problems in chronic inflammatory diseases: prevalence, treatment, and new perspectives: a narrative review</article-title>. <source><italic toggle="yes">J Clin Med</italic></source>. <year>2021</year>;<volume>11</volume>(<issue>1</issue>):<fpage>67</fpage>. doi:<pub-id pub-id-type="doi">10.3390/jcm11010067</pub-id><pub-id pub-id-type="pmid">35011807</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0009">
        <label>9.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Sochal</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Binienda</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Ditmer</surname>
<given-names>M</given-names></string-name>, et al. <article-title>Relation between symptoms of insomnia, depression, sleep quality, anti-tumor necrosis factor therapy and disrupted circadian clock genes’ expression in inflammatory bowel disease</article-title>. <source><italic toggle="yes">Pol Arch Intern Med</italic></source>. <year>2023</year>. doi:<pub-id pub-id-type="doi">10.20452/pamw.16487</pub-id></mixed-citation>
      </ref>
      <ref id="cit0010">
        <label>10.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Sochal</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Ditmer</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Binienda</surname>
<given-names>A</given-names></string-name>, et al. <article-title>Relation between selected sleep parameters, depression, anti-tumor necrosis factor therapy, and the brain-derived neurotrophic factor pathway in inflammatory bowel disease</article-title>. <source><italic toggle="yes">Metabolites</italic></source>. <year>2023</year>;<volume>13</volume>(<issue>3</issue>):<fpage>450</fpage>. doi:<pub-id pub-id-type="doi">10.3390/metabo13030450</pub-id><pub-id pub-id-type="pmid">36984890</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0011">
        <label>11.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Harvey</surname>
<given-names>C-J</given-names></string-name>, <string-name><surname>Gehrman</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Espie</surname>
<given-names>CA</given-names></string-name>. <article-title>Who is predisposed to insomnia: a review of familial aggregation, stress-reactivity, personality and coping style</article-title>. <source><italic toggle="yes">Sleep Med Rev</italic></source>. <year>2014</year>;<volume>18</volume>(<issue>3</issue>):<fpage>237</fpage>–<lpage>247</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.smrv.2013.11.004</pub-id><pub-id pub-id-type="pmid">24480386</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0012">
        <label>12.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Kalmbach</surname>
<given-names>DA</given-names></string-name>, <string-name><surname>Cuamatzi-Castelan</surname>
<given-names>AS</given-names></string-name>, <string-name><surname>Tonnu</surname>
<given-names>CV</given-names></string-name>, et al. <article-title>Hyperarousal and sleep reactivity in insomnia: current insights</article-title>. <source><italic toggle="yes">Nat Sci Sleep</italic></source>. <year>2018</year>;<volume>10</volume>:<fpage>193</fpage>–<lpage>201</lpage>. doi:<pub-id pub-id-type="doi">10.2147/nss.S138823</pub-id><pub-id pub-id-type="pmid">30046255</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0013">
        <label>13.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Spielman</surname>
<given-names>AJ</given-names></string-name>, <string-name><surname>Caruso</surname>
<given-names>LS</given-names></string-name>, <string-name><surname>Glovinsky</surname>
<given-names>PB</given-names></string-name>. <article-title>A behavioral perspective on insomnia treatment</article-title>. <source><italic toggle="yes">Psychiatr Clin North Am</italic></source>. <year>1987</year>;<volume>10</volume>(<issue>4</issue>):<fpage>541</fpage>–<lpage>553</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0193-953X(18)30532-X</pub-id><pub-id pub-id-type="pmid">3332317</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0014">
        <label>14.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Haynes</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Talbert</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Fox</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Close</surname>
<given-names>E</given-names></string-name>. <article-title>Cognitive behavioral therapy in the treatment of insomnia</article-title>. <source><italic toggle="yes">South Med J</italic></source>. <year>2018</year>;<volume>111</volume>(<issue>2</issue>):<fpage>75</fpage>–<lpage>80</lpage>. doi:<pub-id pub-id-type="doi">10.14423/smj.0000000000000769</pub-id><pub-id pub-id-type="pmid">29394420</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0015">
        <label>15.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Riemann</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Baglioni</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Bassetti</surname>
<given-names>C</given-names></string-name>, et al. <article-title>European guideline for the diagnosis and treatment of insomnia</article-title>. <source><italic toggle="yes">J Sleep Res</italic></source>. <year>2017</year>;<volume>26</volume>(<issue>6</issue>):<fpage>675</fpage>–<lpage>700</lpage>. doi:<pub-id pub-id-type="doi">10.1111/jsr.12594</pub-id><pub-id pub-id-type="pmid">28875581</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0016">
        <label>16.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Ballesio</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Zagaria</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Curti</surname>
<given-names>DG</given-names></string-name>, et al. <article-title>Peripheral brain-derived neurotrophic factor (BDNF) in insomnia: a systematic review and meta-analysis</article-title>. <source><italic toggle="yes">Sleep Med Rev</italic></source>. <year>2023</year>;<volume>67</volume>:<fpage>101738</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.smrv.2022.101738</pub-id><pub-id pub-id-type="pmid">36577338</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0017">
        <label>17.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Miranda</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Morici</surname>
<given-names>JF</given-names></string-name>, <string-name><surname>Zanoni</surname>
<given-names>MB</given-names></string-name>, <string-name><surname>Bekinschtein</surname>
<given-names>P</given-names></string-name>. <article-title>Brain-derived neurotrophic factor: a key molecule for memory in the healthy and the pathological brain. Review</article-title>. <source><italic toggle="yes">Front Cell Neurosci</italic></source>. <year>2019</year>;<volume>13</volume>. doi:<pub-id pub-id-type="doi">10.3389/fncel.2019.00363</pub-id></mixed-citation>
      </ref>
      <ref id="cit0018">
        <label>18.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Sochal</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Ditmer</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Gabryelska</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Białasiewicz</surname>
<given-names>P</given-names></string-name>. <article-title>The role of brain-derived neurotrophic factor in immune-related diseases: a narrative review</article-title>. <source><italic toggle="yes">J Clin Med</italic></source>. <year>2022</year>;<volume>11</volume>(<issue>20</issue>):<fpage>6023</fpage>. doi:<pub-id pub-id-type="doi">10.3390/jcm11206023</pub-id><pub-id pub-id-type="pmid">36294343</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0019">
        <label>19.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Chen</surname>
<given-names>SD</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>CL</given-names></string-name>, <string-name><surname>Hwang</surname>
<given-names>WC</given-names></string-name>, <string-name><surname>Yang</surname>
<given-names>DI</given-names></string-name>. <article-title>More insight into BDNF against neurodegeneration: anti-apoptosis, anti-oxidation, and suppression of autophagy</article-title>. <source><italic toggle="yes">Int J Mol Sci</italic></source>. <year>2017</year>;<volume>18</volume>(<issue>3</issue>). doi:<pub-id pub-id-type="doi">10.3390/ijms18030545</pub-id></mixed-citation>
      </ref>
      <ref id="cit0020">
        <label>20.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Rahmani</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Rahmani</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Rezaei</surname>
<given-names>N</given-names></string-name>. <article-title>The brain-derived neurotrophic factor: missing link between sleep deprivation, insomnia, and depression</article-title>. <source><italic toggle="yes">Neurochem Res</italic></source>. <year>2020</year>;<volume>45</volume>(<issue>2</issue>):<fpage>221</fpage>–<lpage>231</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s11064-019-02914-1</pub-id><pub-id pub-id-type="pmid">31782101</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0021">
        <label>21.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Molano</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Vaughn</surname>
<given-names>BV</given-names></string-name>. <article-title>Approach to insomnia in patients with dementia</article-title>. <source><italic toggle="yes">Neurol Clin Pract</italic></source>. <year>2014</year>;<volume>4</volume>(<issue>1</issue>):<fpage>7</fpage>–<lpage>15</lpage>. doi:<pub-id pub-id-type="doi">10.1212/CPJ.0b013e3182a78edf</pub-id><pub-id pub-id-type="pmid">29473586</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0022">
        <label>22.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Nutt</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Wilson</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Paterson</surname>
<given-names>L</given-names></string-name>. <article-title>Sleep disorders as core symptoms of depression</article-title>. <source><italic toggle="yes">Dialogues Clin Neurosci</italic></source>. <year>2008</year>;<volume>10</volume>(<issue>3</issue>):<fpage>329</fpage>–<lpage>336</lpage>. doi:<pub-id pub-id-type="doi">10.31887/DCNS.2008.10.3/dnutt</pub-id><pub-id pub-id-type="pmid">18979946</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0023">
        <label>23.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Gao</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Sterling</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Song</surname>
<given-names>W</given-names></string-name>. <article-title>Brain-derived neurotrophic factor in Alzheimer’s disease and its pharmaceutical potential</article-title>. <source><italic toggle="yes">Transl Neurodegener</italic></source>. <year>2022</year>;<volume>11</volume>(<issue>1</issue>):<fpage>4</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s40035-022-00279-0</pub-id><pub-id pub-id-type="pmid">35090576</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0024">
        <label>24.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Nazareth</surname>
<given-names>AM</given-names></string-name>. <article-title>BDNF, A focus to major depression</article-title>. <source><italic toggle="yes">Open J Psychol</italic></source>. <year>2021</year>;<volume>1</volume>(<issue>1</issue>):<fpage>10</fpage>–<lpage>21</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0025">
        <label>25.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Rosenfeld</surname>
<given-names>RD</given-names></string-name>, <string-name><surname>Zeni</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Haniu</surname>
<given-names>N</given-names></string-name>, et al. <article-title>Purification and identification of brain-derived neurotrophic factor from human serum</article-title>. <source><italic toggle="yes">Protein Expr Purif</italic></source>. <year>1995</year>;<volume>6</volume>(<issue>4</issue>):<fpage>465</fpage>–<lpage>471</lpage>. doi:<pub-id pub-id-type="doi">10.1006/prep.1995.1062</pub-id><pub-id pub-id-type="pmid">8527932</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0026">
        <label>26.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Gabryelska</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Turkiewicz</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Ditmer</surname>
<given-names>M</given-names></string-name>, et al. <article-title>BDNF and proBDNF serum protein levels in obstructive sleep apnea patients and their involvement in insomnia and depression symptoms</article-title>. <source><italic toggle="yes">J Clin Med</italic></source>. <year>2022</year>;<volume>11</volume>(<issue>23</issue>):<fpage>7135</fpage>. doi:<pub-id pub-id-type="doi">10.3390/jcm11237135</pub-id><pub-id pub-id-type="pmid">36498709</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0027">
        <label>27.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Gabryelska</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Sochal</surname>
<given-names>M</given-names></string-name>. <article-title>Evaluation of HIF-1 involvement in the BDNF and ProBDNF signaling pathways among obstructive sleep apnea patients</article-title>. <source><italic toggle="yes">Int J Mol Sci</italic></source>. <year>2022</year>;<volume>23</volume>(<issue>23</issue>):<fpage>14876</fpage>. doi:<pub-id pub-id-type="doi">10.3390/ijms232314876</pub-id><pub-id pub-id-type="pmid">36499215</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0028">
        <label>28.</label>
        <mixed-citation publication-type="journal"><string-name><surname>S-Y</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Pan</surname>
<given-names>B-S</given-names></string-name>, <string-name><surname>Tsai</surname>
<given-names>S-F</given-names></string-name>, et al. <article-title>BDNF reverses aging-related microglial activation</article-title>. <source><italic toggle="yes">J Neuroinflam</italic></source>. <year>2020</year>;<volume>17</volume>(<issue>1</issue>):<fpage>210</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s12974-020-01887-1</pub-id></mixed-citation>
      </ref>
      <ref id="cit0029">
        <label>29.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Walsh</surname>
<given-names>EI</given-names></string-name>, <string-name><surname>Smith</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Northey</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Rattray</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Cherbuin</surname>
<given-names>N</given-names></string-name>. <article-title>Towards an understanding of the physical activity-BDNF-cognition triumvirate: a review of associations and dosage</article-title>. <source><italic toggle="yes">Ageing Res Rev</italic></source>. <year>2020</year>;<volume>60</volume>:<fpage>101044</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.arr.2020.101044</pub-id><pub-id pub-id-type="pmid">32171785</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0030">
        <label>30.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Causing</surname>
<given-names>CG</given-names></string-name>, <string-name><surname>Gloster</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Aloyz</surname>
<given-names>R</given-names></string-name>, et al. <article-title>Synaptic innervation density is regulated by neuron-derived BDNF</article-title>. <source><italic toggle="yes">Neuron</italic></source>. <year>1997</year>;<volume>18</volume>(<issue>2</issue>):<fpage>257</fpage>–<lpage>267</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0896-6273(00)80266-4</pub-id><pub-id pub-id-type="pmid">9052796</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0031">
        <label>31.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Alonso</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Medina</surname>
<given-names>JH</given-names></string-name>, <string-name><surname>Pozzo-Miller</surname>
<given-names>L</given-names></string-name>. <article-title>ERK1/2 activation is necessary for BDNF to increase dendritic spine density in hippocampal CA1 pyramidal neurons</article-title>. <source><italic toggle="yes">Learn Mem</italic></source>. <year>2004</year>;<volume>11</volume>(<issue>2</issue>):<fpage>172</fpage>–<lpage>178</lpage>. doi:<pub-id pub-id-type="doi">10.1101/lm.67804</pub-id><pub-id pub-id-type="pmid">15054132</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0032">
        <label>32.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Horch</surname>
<given-names>HW</given-names></string-name>, <string-name><surname>Krüttgen</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Portbury</surname>
<given-names>SD</given-names></string-name>, <string-name><surname>Katz</surname>
<given-names>LC</given-names></string-name>. <article-title>Destabilization of cortical dendrites and spines by BDNF</article-title>. <source><italic toggle="yes">Neuron</italic></source>. <year>1999</year>;<volume>23</volume>(<issue>2</issue>):<fpage>353</fpage>–<lpage>364</lpage>. doi:<pub-id pub-id-type="doi">10.1016/s0896-6273(00)80785-0</pub-id><pub-id pub-id-type="pmid">10399940</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0033">
        <label>33.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Lom</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Cohen-Cory</surname>
<given-names>S</given-names></string-name>. <article-title>Brain-derived neurotrophic factor differentially regulates retinal ganglion cell dendritic and axonal arborization in vivo</article-title>. <source><italic toggle="yes">J Neurosci</italic></source>. <year>1999</year>;<volume>19</volume>(<issue>22</issue>):<fpage>9928</fpage>–<lpage>9938</lpage>. doi:<pub-id pub-id-type="doi">10.1523/jneurosci.19-22-09928.1999</pub-id><pub-id pub-id-type="pmid">10559401</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0034">
        <label>34.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Niblock</surname>
<given-names>MM</given-names></string-name>, <string-name><surname>Brunso-Bechtold</surname>
<given-names>JK</given-names></string-name>, <string-name><surname>Riddle</surname>
<given-names>DR</given-names></string-name>. <article-title>Insulin-like growth factor I stimulates dendritic growth in primary somatosensory cortex</article-title>. <source><italic toggle="yes">J Neurosci</italic></source>. <year>2000</year>;<volume>20</volume>(<issue>11</issue>):<fpage>4165</fpage>. doi:<pub-id pub-id-type="doi">10.1523/JNEUROSCI.20-11-04165.2000</pub-id><pub-id pub-id-type="pmid">10818152</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0035">
        <label>35.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Kwon</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Fernández</surname>
<given-names>JR</given-names></string-name>, <string-name><surname>Zegarek</surname>
<given-names>GF</given-names></string-name>, <string-name><surname>Lo</surname>
<given-names>SB</given-names></string-name>, <string-name><surname>Firestein</surname>
<given-names>BL</given-names></string-name>. <article-title>BDNF-promoted increases in proximal dendrites occur via CREB-dependent transcriptional regulation of cypin</article-title>. <source><italic toggle="yes">J Neurosci</italic></source>. <year>2011</year>;<volume>31</volume>(<issue>26</issue>):<fpage>9735</fpage>–<lpage>9745</lpage>. doi:<pub-id pub-id-type="doi">10.1523/jneurosci.6785-10.2011</pub-id><pub-id pub-id-type="pmid">21715638</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0036">
        <label>36.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Jovanovic</surname>
<given-names>JN</given-names></string-name>, <string-name><surname>Czernik</surname>
<given-names>AJ</given-names></string-name>, <string-name><surname>Fienberg</surname>
<given-names>AA</given-names></string-name>, <string-name><surname>Greengard</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Sihra</surname>
<given-names>TS</given-names></string-name>. <article-title>Synapsins as mediators of BDNF-enhanced neurotransmitter release</article-title>. <source><italic toggle="yes">Nat Neurosci</italic></source>. <year>2000</year>;<volume>3</volume>(<issue>4</issue>):<fpage>323</fpage>–<lpage>329</lpage>. doi:<pub-id pub-id-type="doi">10.1038/73888</pub-id><pub-id pub-id-type="pmid">10725920</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0037">
        <label>37.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Pascual</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Climent</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Guerri</surname>
<given-names>C</given-names></string-name>. <article-title>BDNF induces glutamate release in cerebrocortical nerve terminals and in cortical astrocytes</article-title>. <source><italic toggle="yes">NeuroReport</italic></source>. <year>2001</year>;<volume>12</volume>(<issue>12</issue>):<fpage>2673</fpage>–<lpage>2677</lpage>. doi:<pub-id pub-id-type="doi">10.1097/00001756-200108280-00017</pub-id><pub-id pub-id-type="pmid">11522946</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0038">
        <label>38.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Chen</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Xiong</surname>
<given-names>LJ</given-names></string-name>, <string-name><surname>Tong</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Mao</surname>
<given-names>M</given-names></string-name>. <article-title>Neuroprotective effect of brain-derived neurotrophic factor mediated by autophagy through the PI3K/Akt/mTOR pathway</article-title>. <source><italic toggle="yes">Mol Med Rep</italic></source>. <year>2013</year>;<volume>8</volume>(<issue>4</issue>):<fpage>1011</fpage>–<lpage>1016</lpage>. doi:<pub-id pub-id-type="doi">10.3892/mmr.2013.1628</pub-id><pub-id pub-id-type="pmid">23942837</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0039">
        <label>39.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Caldeira</surname>
<given-names>MV</given-names></string-name>, <string-name><surname>Melo</surname>
<given-names>CV</given-names></string-name>, <string-name><surname>Pereira</surname>
<given-names>DB</given-names></string-name>, et al. <article-title>Brain-derived neurotrophic factor regulates the expression and synaptic delivery of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor subunits in hippocampal neurons</article-title>. <source><italic toggle="yes">J Biol Chem</italic></source>. <year>2007</year>;<volume>282</volume>(<issue>17</issue>):<fpage>12619</fpage>–<lpage>12628</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.M700607200</pub-id><pub-id pub-id-type="pmid">17337442</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0040">
        <label>40.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Lin</surname>
<given-names>SY</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Levine</surname>
<given-names>ES</given-names></string-name>, <string-name><surname>Mount</surname>
<given-names>HT</given-names></string-name>, <string-name><surname>Suen</surname>
<given-names>PC</given-names></string-name>, <string-name><surname>Black</surname>
<given-names>IB</given-names></string-name>. <article-title>BDNF acutely increases tyrosine phosphorylation of the NMDA receptor subunit 2B in cortical and hippocampal postsynaptic densities</article-title>. <source><italic toggle="yes">Brain Res Mol Brain Res</italic></source>. <year>1998</year>;<volume>55</volume>(<issue>1</issue>):<fpage>20</fpage>–<lpage>27</lpage>. doi:<pub-id pub-id-type="doi">10.1016/s0169-328x(97)00349-5</pub-id><pub-id pub-id-type="pmid">9645956</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0041">
        <label>41.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Suen</surname>
<given-names>P-C</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Levine</surname>
<given-names>ES</given-names></string-name>, et al. <article-title>Brain-derived neurotrophic factor rapidly enhances phosphorylation of the postsynaptic N-methyl-d-aspartate receptor subunit 1</article-title>. <source><italic toggle="yes">Proc Natl Acad Sci</italic></source>. <year>1997</year>;<volume>94</volume>(<issue>15</issue>):<fpage>8191</fpage>–<lpage>8195</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.94.15.8191</pub-id><pub-id pub-id-type="pmid">9223337</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0042">
        <label>42.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Almeida</surname>
<given-names>RD</given-names></string-name>, <string-name><surname>Manadas</surname>
<given-names>BJ</given-names></string-name>, <string-name><surname>Melo</surname>
<given-names>CV</given-names></string-name>, et al. <article-title>Neuroprotection by BDNF against glutamate-induced apoptotic cell death is mediated by ERK and PI3-kinase pathways</article-title>. <source><italic toggle="yes">Cell Death Differ</italic></source>. <year>2005</year>;<volume>12</volume>(<issue>10</issue>):<fpage>1329</fpage>–<lpage>1343</lpage>. doi:<pub-id pub-id-type="doi">10.1038/sj.cdd.4401662</pub-id><pub-id pub-id-type="pmid">15905876</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0043">
        <label>43.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Porcher</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Medina</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Gaiarsa</surname>
<given-names>JL</given-names></string-name>. <article-title>Mechanism of BDNF modulation in GABAergic synaptic transmission in healthy and disease brains</article-title>. <source><italic toggle="yes">Front Cell Neurosci</italic></source>. <year>2018</year>;<volume>12</volume>:<fpage>273</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fncel.2018.00273</pub-id><pub-id pub-id-type="pmid">30210299</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0044">
        <label>44.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Song</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>C-H</given-names></string-name>, <string-name><surname>Song</surname>
<given-names>H-T</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>JE</given-names></string-name>. <article-title>The role of orexin in post-stroke inflammation, cognitive decline, and depression</article-title>. <source><italic toggle="yes">Molecular Brain</italic></source>. <year>2015</year>;<volume>8</volume>(<issue>1</issue>):<fpage>16</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s13041-015-0106-1</pub-id><pub-id pub-id-type="pmid">25884812</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0045">
        <label>45.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Guo</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Feng</surname>
<given-names>P</given-names></string-name>. <article-title>OX2R activation induces PKC-mediated ERK and CREB phosphorylation</article-title>. <source><italic toggle="yes">Exp Cell Res</italic></source>. <year>2012</year>;<volume>318</volume>(<issue>16</issue>):<fpage>2004</fpage>–<lpage>2013</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.yexcr.2012.04.015</pub-id><pub-id pub-id-type="pmid">22652455</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0046">
        <label>46.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Erman</surname>
<given-names>MK</given-names></string-name>. <article-title>Sleep architecture and its relationship to insomnia</article-title>. <source><italic toggle="yes">J Clin Psychiatry</italic></source>. <year>2001</year>;<volume>62</volume>(<issue>Suppl 10</issue>):<fpage>9</fpage>–<lpage>17</lpage>.<pub-id pub-id-type="pmid">11388592</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0047">
        <label>47.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Yetton</surname>
<given-names>BD</given-names></string-name>, <string-name><surname>McDevitt</surname>
<given-names>EA</given-names></string-name>, <string-name><surname>Cellini</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Shelton</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Mednick</surname>
<given-names>SC</given-names></string-name>. <article-title>Quantifying sleep architecture dynamics and individual differences using big data and Bayesian networks</article-title>. <source><italic toggle="yes">PLoS One</italic></source>. <year>2018</year>;<volume>13</volume>(<issue>4</issue>):<fpage>e0194604</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0194604</pub-id><pub-id pub-id-type="pmid">29641599</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0048">
        <label>48.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Drake</surname>
<given-names>CL</given-names></string-name>, <string-name><surname>Roehrs</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Roth</surname>
<given-names>T</given-names></string-name>. <article-title>Insomnia causes, consequences, and therapeutics: an overview</article-title>. <source><italic toggle="yes">Depress Anxiety</italic></source>. <year>2003</year>;<volume>18</volume>(<issue>4</issue>):<fpage>163</fpage>–<lpage>176</lpage>. doi:<pub-id pub-id-type="doi">10.1002/da.10151</pub-id><pub-id pub-id-type="pmid">14661186</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0049">
        <label>49.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Moline</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Murphy</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Pinner</surname>
<given-names>K</given-names></string-name>, et al. <article-title>0369 effect of lemborexant on sleep architecture in older adults with insomnia disorder</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2019</year>;<volume>42</volume>(<issue>Supplement_1</issue>):<fpage>A150</fpage>–<lpage>A150</lpage>. doi:<pub-id pub-id-type="doi">10.1093/sleep/zsz067.368</pub-id></mixed-citation>
      </ref>
      <ref id="cit0050">
        <label>50.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Watson</surname>
<given-names>AJ</given-names></string-name>, <string-name><surname>Henson</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Dorsey</surname>
<given-names>SG</given-names></string-name>, <string-name><surname>Frank</surname>
<given-names>MG</given-names></string-name>. <article-title>The truncated TrkB receptor influences mammalian sleep</article-title>. <source><italic toggle="yes">Am J Physiol Regul Integr Comp Physiol</italic></source>. <year>2015</year>;<volume>308</volume>(<issue>3</issue>):<fpage>R199</fpage>–<lpage>R207</lpage>. doi:<pub-id pub-id-type="doi">10.1152/ajpregu.00422.2014</pub-id><pub-id pub-id-type="pmid">25502751</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0051">
        <label>51.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Garner</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Chambers</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Barnes</surname>
<given-names>AK</given-names></string-name>, <string-name><surname>Datta</surname>
<given-names>S</given-names></string-name>. <article-title>Changes in brain-derived neurotrophic factor expression influence sleep-wake activity and homeostatic regulation of rapid eye movement sleep</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2018</year>;<volume>41</volume>(<issue>2</issue>). doi:<pub-id pub-id-type="doi">10.1093/sleep/zsx194</pub-id></mixed-citation>
      </ref>
      <ref id="cit0052">
        <label>52.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Henechowicz</surname>
<given-names>TL</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>JL</given-names></string-name>, <string-name><surname>Cohen</surname>
<given-names>LG</given-names></string-name>, <string-name><surname>Thaut</surname>
<given-names>MH</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>Z</given-names></string-name>. <article-title>The prevalence of the Val66Met polymorphism in musicians: possible evidence for compensatory neuroplasticity from a pilot study</article-title>. <source><italic toggle="yes">PLoS One</italic></source>. <year>2021</year>;<volume>16</volume>(<issue>6</issue>):<fpage>e0245107</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0245107</pub-id><pub-id pub-id-type="pmid">34106930</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0053">
        <label>53.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Greene</surname>
<given-names>RW</given-names></string-name>, <string-name><surname>Frank</surname>
<given-names>MG</given-names></string-name>. <article-title>Slow wave activity during sleep: functional and therapeutic implications</article-title>. <source><italic toggle="yes">Neuroscientist</italic></source>. <year>2010</year>;<volume>16</volume>(<issue>6</issue>):<fpage>618</fpage>–<lpage>633</lpage>. doi:<pub-id pub-id-type="doi">10.1177/1073858410377064</pub-id><pub-id pub-id-type="pmid">20921564</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0054">
        <label>54.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Mongrain</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Warby</surname>
<given-names>SC</given-names></string-name>. <article-title>Determinants of cortical synchrony</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2012</year>;<volume>35</volume>(<issue>3</issue>):<fpage>309</fpage>–<lpage>310</lpage>. doi:<pub-id pub-id-type="doi">10.5665/sleep.1680</pub-id><pub-id pub-id-type="pmid">22379234</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0055">
        <label>55.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Monteiro</surname>
<given-names>BC</given-names></string-name>, <string-name><surname>Monteiro</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Candida</surname>
<given-names>M</given-names></string-name>, et al. <article-title>Relationship between brain-derived neurotrofic factor (Bdnf) and sleep on depression: a critical review</article-title>. <source><italic toggle="yes">Clin Pract Epidemiol Ment Health</italic></source>. <year>2017</year>;<volume>13</volume>(<issue>1</issue>):<fpage>213</fpage>–<lpage>219</lpage>. doi:<pub-id pub-id-type="doi">10.2174/1745017901713010213</pub-id><pub-id pub-id-type="pmid">29299044</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0056">
        <label>56.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Kushikata</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Kubota</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Fang</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Krueger</surname>
<given-names>JM</given-names></string-name>. <article-title>Neurotrophins 3 and 4 enhance non-rapid eye movement sleep in rabbits</article-title>. <source><italic toggle="yes">Neurosci Lett</italic></source>. <year>2003</year>;<volume>346</volume>(<issue>3</issue>):<fpage>161</fpage>–<lpage>164</lpage>. doi:<pub-id pub-id-type="doi">10.1016/s0304-3940(03)00564-0</pub-id><pub-id pub-id-type="pmid">12853109</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0057">
        <label>57.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Faraguna</surname>
<given-names>U</given-names></string-name>, <string-name><surname>Vyazovskiy</surname>
<given-names>VV</given-names></string-name>, <string-name><surname>Nelson</surname>
<given-names>AB</given-names></string-name>, <string-name><surname>Tononi</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Cirelli</surname>
<given-names>C</given-names></string-name>. <article-title>A causal role for brain-derived neurotrophic factor in the homeostatic regulation of sleep</article-title>. <source><italic toggle="yes">J Neurosci</italic></source>. <year>2008</year>;<volume>28</volume>(<issue>15</issue>):<fpage>4088</fpage>–<lpage>4095</lpage>. doi:<pub-id pub-id-type="doi">10.1523/jneurosci.5510-07.2008</pub-id><pub-id pub-id-type="pmid">18400908</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0058">
        <label>58.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Muheim</surname>
<given-names>CM</given-names></string-name>, <string-name><surname>Singletary</surname>
<given-names>KG</given-names></string-name>, <string-name><surname>Frank</surname>
<given-names>MG</given-names></string-name>. <article-title>A chemical-genetic investigation of BDNF-NtrkB signaling in mammalian sleep</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2022</year>;<volume>45</volume>(<issue>2</issue>). doi:<pub-id pub-id-type="doi">10.1093/sleep/zsab237</pub-id></mixed-citation>
      </ref>
      <ref id="cit0059">
        <label>59.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Kaczmarski</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Sochal</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Strzelecki</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Białasiewicz</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Gabryelska</surname>
<given-names>A</given-names></string-name>. <article-title>Influence of glutamatergic and GABAergic neurotransmission on obstructive sleep apnea. Review</article-title>. <source><italic toggle="yes">Front Neurosci</italic></source>. <year>2023</year>;<volume>17</volume>. doi:<pub-id pub-id-type="doi">10.3389/fnins.2023.1213971</pub-id></mixed-citation>
      </ref>
      <ref id="cit0060">
        <label>60.</label>
        <mixed-citation publication-type="book"><string-name><surname>Reddy</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Reddy</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Sharma</surname>
<given-names>S</given-names></string-name>. <part-title>Physiology, circadian rhythm</part-title>. In: <source><italic toggle="yes">StatPearls</italic></source>. <publisher-name>StatPearls Publishing Copyright © 2023, StatPearls Publishing LLC.</publisher-name>; <year>2023</year>.</mixed-citation>
      </ref>
      <ref id="cit0061">
        <label>61.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Gabryelska</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Turkiewicz</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Karuga</surname>
<given-names>FF</given-names></string-name>, <string-name><surname>Sochal</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Strzelecki</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Białasiewicz</surname>
<given-names>P</given-names></string-name>. <article-title>Disruption of circadian rhythm genes in obstructive sleep apnea patients—possible mechanisms involved and clinical implication</article-title>. <source><italic toggle="yes">Int J Mol Sci</italic></source>. <year>2022</year>;<volume>23</volume>(<issue>2</issue>):<fpage>709</fpage>. doi:<pub-id pub-id-type="doi">10.3390/ijms23020709</pub-id><pub-id pub-id-type="pmid">35054894</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0062">
        <label>62.</label>
        <mixed-citation publication-type="book"><string-name><surname>Reid</surname>
<given-names>KJ</given-names></string-name>, <string-name><surname>Zee</surname>
<given-names>PC</given-names></string-name>. <part-title>Chapter 41 - circadian disorders of the sleep–wake cycle</part-title>. In: <string-name><surname>Kryger</surname>
<given-names>MH</given-names></string-name>, <string-name><surname>Roth</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Dement</surname>
<given-names>WC</given-names></string-name>, editors. <source><italic toggle="yes">Principles and Practice of Sleep Medicine</italic></source>. <edition>5th</edition> ed. <publisher-name>W.B. Saunders</publisher-name>; <year>2011</year>:<fpage>470</fpage>–<lpage>482</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0063">
        <label>63.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Sack</surname>
<given-names>RL</given-names></string-name>, <string-name><surname>Auckley</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Auger</surname>
<given-names>RR</given-names></string-name>, et al. <article-title>Circadian rhythm sleep disorders: part I, basic principles, shift work and jet lag disorders. An American Academy of Sleep Medicine review</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2007</year>;<volume>30</volume>(<issue>11</issue>):<fpage>1460</fpage>–<lpage>1483</lpage>. doi:<pub-id pub-id-type="doi">10.1093/sleep/30.11.1460</pub-id><pub-id pub-id-type="pmid">18041480</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0064">
        <label>64.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Archer</surname>
<given-names>SN</given-names></string-name>, <string-name><surname>Carpen</surname>
<given-names>JD</given-names></string-name>, <string-name><surname>Gibson</surname>
<given-names>M</given-names></string-name>, et al. <article-title>Polymorphism in the PER3 promoter associates with diurnal preference and delayed sleep phase disorder</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2010</year>;<volume>33</volume>(<issue>5</issue>):<fpage>695</fpage>–<lpage>701</lpage>. doi:<pub-id pub-id-type="doi">10.1093/sleep/33.5.695</pub-id><pub-id pub-id-type="pmid">20469812</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0065">
        <label>65.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Semenova</surname>
<given-names>NV</given-names></string-name>, <string-name><surname>Madaeva</surname>
<given-names>IM</given-names></string-name>, <string-name><surname>Bairova</surname>
<given-names>TI</given-names></string-name>, et al. <article-title>3111T/C clock gene polymorphism in women with insomnia</article-title>. <source><italic toggle="yes">Bull Exp Biol Med</italic></source>. <year>2017</year>;<volume>163</volume>(<issue>4</issue>):<fpage>461</fpage>–<lpage>464</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s10517-017-3828-5</pub-id><pub-id pub-id-type="pmid">28853078</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0066">
        <label>66.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Charrier</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Olliac</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Roubertoux</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Tordjman</surname>
<given-names>S</given-names></string-name>. <article-title>Clock genes and altered sleep-wake rhythms: their role in the development of psychiatric disorders</article-title>. <source><italic toggle="yes">Int J Mol Sci</italic></source>. <year>2017</year>;<volume>18</volume>(<issue>5</issue>):<fpage>938</fpage>. doi:<pub-id pub-id-type="doi">10.3390/ijms18050938</pub-id><pub-id pub-id-type="pmid">28468274</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0067">
        <label>67.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Wickwire</surname>
<given-names>EM</given-names></string-name>, <string-name><surname>Geiger-Brown</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Scharf</surname>
<given-names>SM</given-names></string-name>, <string-name><surname>Drake</surname>
<given-names>CL</given-names></string-name>. <article-title>Shift work and shift work sleep disorder: clinical and organizational perspectives</article-title>. <source><italic toggle="yes">Chest</italic></source>. <year>2017</year>;<volume>151</volume>(<issue>5</issue>):<fpage>1156</fpage>–<lpage>1172</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.chest.2016.12.007</pub-id><pub-id pub-id-type="pmid">28012806</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0068">
        <label>68.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Liang</surname>
<given-names>FQ</given-names></string-name>, <string-name><surname>Sohrabji</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Miranda</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Earnest</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Earnest</surname>
<given-names>D</given-names></string-name>. <article-title>Expression of brain-derived neurotrophic factor and its cognate receptor, TrkB, in the rat suprachiasmatic nucleus</article-title>. <source><italic toggle="yes">Exp Neurol</italic></source>. <year>1998</year>;<volume>151</volume>(<issue>2</issue>):<fpage>184</fpage>–<lpage>193</lpage>. doi:<pub-id pub-id-type="doi">10.1006/exnr.1998.6804</pub-id><pub-id pub-id-type="pmid">9628753</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0069">
        <label>69.</label>
        <mixed-citation publication-type="journal"><string-name><surname>D’Agostino</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Frigato</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Noviello</surname>
<given-names>TMR</given-names></string-name>, et al. <article-title>Loss of circadian rhythmicity in bdnf knockout zebrafish larvae</article-title>. <source><italic toggle="yes">iScience</italic></source>. <year>2022</year>;<volume>25</volume>(<issue>4</issue>):<fpage>104054</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.isci.2022.104054</pub-id><pub-id pub-id-type="pmid">35345456</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0070">
        <label>70.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Cain</surname>
<given-names>SW</given-names></string-name>, <string-name><surname>Chang</surname>
<given-names>AM</given-names></string-name>, <string-name><surname>Vlasac</surname>
<given-names>I</given-names></string-name>, et al. <article-title>Circadian rhythms in plasma brain-derived neurotrophic factor differ in men and women</article-title>. <source><italic toggle="yes">J Biol Rhythms</italic></source>. <year>2017</year>;<volume>32</volume>(<issue>1</issue>):<fpage>75</fpage>–<lpage>82</lpage>. doi:<pub-id pub-id-type="doi">10.1177/0748730417693124</pub-id><pub-id pub-id-type="pmid">28326910</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0071">
        <label>71.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Piccinni</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Marazziti</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Del Debbio</surname>
<given-names>A</given-names></string-name>, et al. <article-title>Diurnal variation of plasma brain-derived neurotrophic factor (BDNF) in humans: an analysis of sex differences</article-title>. <source><italic toggle="yes">Chronobiol Int</italic></source>. <year>2008</year>;<volume>25</volume>(<issue>5</issue>):<fpage>819</fpage>–<lpage>826</lpage>. doi:<pub-id pub-id-type="doi">10.1080/07420520802387773</pub-id><pub-id pub-id-type="pmid">18780207</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0072">
        <label>72.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Choi</surname>
<given-names>SW</given-names></string-name>, <string-name><surname>Bhang</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Ahn</surname>
<given-names>JH</given-names></string-name>. <article-title>Diurnal variation and gender differences of plasma brain-derived neurotrophic factor in healthy human subjects</article-title>. <source><italic toggle="yes">Psychiatry Res</italic></source>. <year>2011</year>;<volume>186</volume>(<issue>2–3</issue>):<fpage>427</fpage>–<lpage>430</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.psychres.2010.07.028</pub-id><pub-id pub-id-type="pmid">20826006</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0073">
        <label>73.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Begliuomini</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Lenzi</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Ninni</surname>
<given-names>F</given-names></string-name>, et al. <article-title>Plasma brain-derived neurotrophic factor daily variations in men: correlation with cortisol circadian rhythm</article-title>. <source><italic toggle="yes">J Endocrinol</italic></source>. <year>2008</year>;<volume>197</volume>(<issue>2</issue>):<fpage>429</fpage>–<lpage>435</lpage>. doi:<pub-id pub-id-type="doi">10.1677/joe-07-0376</pub-id><pub-id pub-id-type="pmid">18434373</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0074">
        <label>74.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Miranda-Riestra</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Estrada-Reyes</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Torres-Sanchez</surname>
<given-names>ED</given-names></string-name>, <string-name><surname>Carreño-García</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Ortiz</surname>
<given-names>GG</given-names></string-name>, <string-name><surname>Benítez-King</surname>
<given-names>GM</given-names></string-name>. <article-title>A neurotrophic factor?</article-title>
<source><italic toggle="yes">Molecules</italic></source>. <year>2022</year>;<volume>27</volume>(<issue>22</issue>):<fpage>7742</fpage>. doi:<pub-id pub-id-type="doi">10.3390/molecules27227742</pub-id><pub-id pub-id-type="pmid">36431847</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0075">
        <label>75.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Shokri-Mashhadi</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Darand</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Rouhani</surname>
<given-names>MH</given-names></string-name>, <string-name><surname>Yahay</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Feltham</surname>
<given-names>BA</given-names></string-name>, <string-name><surname>Saraf-Bank</surname>
<given-names>S</given-names></string-name>. <article-title>Effects of melatonin supplementation on BDNF concentrations and depression: a systematic review and meta-analysis of randomized controlled trials</article-title>. <source><italic toggle="yes">Behav Brain Res</italic></source>. <year>2023</year>;<volume>436</volume>:<fpage>114083</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bbr.2022.114083</pub-id><pub-id pub-id-type="pmid">36049659</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0076">
        <label>76.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Otsuka</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Itani</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Matsumoto</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Kaneita</surname>
<given-names>Y</given-names></string-name>. <article-title>Associations between coping strategies and insomnia: a longitudinal study of Japanese workers</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2022</year>;<volume>45</volume>(<issue>2</issue>). doi:<pub-id pub-id-type="doi">10.1093/sleep/zsab244</pub-id></mixed-citation>
      </ref>
      <ref id="cit0077">
        <label>77.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Kowalczuk</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Krajewska-Kułak</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Sobolewski</surname>
<given-names>M</given-names></string-name>. <article-title>Relationships between sleep problems and stress coping strategies adopted by nurses including socio-occupational factors</article-title>. <source><italic toggle="yes">Front Psychiatry</italic></source>. <year>2021</year>;<volume>12</volume>:<fpage>660776</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fpsyt.2021.660776</pub-id><pub-id pub-id-type="pmid">34177648</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0078">
        <label>78.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Serafin</surname>
<given-names>LI</given-names></string-name>, <string-name><surname>Fukowska</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Zyskowska</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Olechowska</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Czarkowska-Pączek</surname>
<given-names>B</given-names></string-name>. <article-title>Impact of stress and coping strategies on insomnia among Polish novice nurses who are employed in their field while continuing their education: a cross-sectional study</article-title>. <source><italic toggle="yes">BMJ Open</italic></source>. <year>2021</year>;<volume>11</volume>(<issue>12</issue>):<fpage>e049787</fpage>. doi:<pub-id pub-id-type="doi">10.1136/bmjopen-2021-049787</pub-id></mixed-citation>
      </ref>
      <ref id="cit0079">
        <label>79.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Soehner</surname>
<given-names>AM</given-names></string-name>, <string-name><surname>Harvey</surname>
<given-names>AG</given-names></string-name>. <article-title>Prevalence and functional consequences of severe insomnia symptoms in mood and anxiety disorders: results from a nationally representative sample</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2012</year>;<volume>35</volume>(<issue>10</issue>):<fpage>1367</fpage>–<lpage>1375</lpage>. doi:<pub-id pub-id-type="doi">10.5665/sleep.2116</pub-id><pub-id pub-id-type="pmid">23024435</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0080">
        <label>80.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Neckelmann</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Mykletun</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Dahl</surname>
<given-names>AA</given-names></string-name>. <article-title>Chronic insomnia as a risk factor for developing anxiety and depression</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2007</year>;<volume>30</volume>(<issue>7</issue>):<fpage>873</fpage>–<lpage>880</lpage>. doi:<pub-id pub-id-type="doi">10.1093/sleep/30.7.873</pub-id><pub-id pub-id-type="pmid">17682658</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0081">
        <label>81.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Cano</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Mochizuki</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Saper</surname>
<given-names>CB</given-names></string-name>. <article-title>Neural circuitry of stress-induced insomnia in rats</article-title>. <source><italic toggle="yes">J Neurosci</italic></source>. <year>2008</year>;<volume>28</volume>(<issue>40</issue>):<fpage>10167</fpage>–<lpage>10184</lpage>. doi:<pub-id pub-id-type="doi">10.1523/jneurosci.1809-08.2008</pub-id><pub-id pub-id-type="pmid">18829974</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0082">
        <label>82.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Dressle</surname>
<given-names>RJ</given-names></string-name>, <string-name><surname>Riemann</surname>
<given-names>D</given-names></string-name>. <article-title>Hyperarousal in insomnia disorder: current evidence and potential mechanisms</article-title>. <source><italic toggle="yes">J Sleep Res</italic></source>. <year>2023</year>;<fpage>e13928</fpage>. doi:<pub-id pub-id-type="doi">10.1111/jsr.13928</pub-id><pub-id pub-id-type="pmid">37183177</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0083">
        <label>83.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Riemann</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Spiegelhalder</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Feige</surname>
<given-names>B</given-names></string-name>, et al. <article-title>The hyperarousal model of insomnia: a review of the concept and its evidence</article-title>. <source><italic toggle="yes">Sleep Med Rev</italic></source>. <year>2010</year>;<volume>14</volume>(<issue>1</issue>):<fpage>19</fpage>–<lpage>31</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.smrv.2009.04.002</pub-id><pub-id pub-id-type="pmid">19481481</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0084">
        <label>84.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Sudheimer</surname>
<given-names>KD</given-names></string-name>, <string-name><surname>O’Hara</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Spiegel</surname>
<given-names>D</given-names></string-name>, et al. <article-title>Cortisol, cytokines, and hippocampal volume interactions in the elderly. Original Research</article-title>. <source><italic toggle="yes">Front Aging Neurosci</italic></source>. <year>2014</year>;<volume>6</volume>. doi:<pub-id pub-id-type="doi">10.3389/fnagi.2014.00153</pub-id></mixed-citation>
      </ref>
      <ref id="cit0085">
        <label>85.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Hall</surname>
<given-names>BS</given-names></string-name>, <string-name><surname>Moda</surname>
<given-names>RN</given-names></string-name>, <string-name><surname>Liston</surname>
<given-names>C</given-names></string-name>. <article-title>Glucocorticoid mechanisms of functional connectivity changes in stress-related neuropsychiatric disorders</article-title>. <source><italic toggle="yes">Neurobiol Stress</italic></source>. <year>2015</year>;<volume>1</volume>:<fpage>174</fpage>–<lpage>183</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ynstr.2014.10.008</pub-id><pub-id pub-id-type="pmid">25729760</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0086">
        <label>86.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Jeanneteau</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Chao</surname>
<given-names>MV</given-names></string-name>. <article-title>Are BDNF and glucocorticoid activities calibrated?</article-title>
<source><italic toggle="yes">Neuroscience</italic></source>. <year>2013</year>;<volume>239</volume>:<fpage>173</fpage>–<lpage>195</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuroscience.2012.09.017</pub-id><pub-id pub-id-type="pmid">23022538</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0087">
        <label>87.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Dressle</surname>
<given-names>RJ</given-names></string-name>, <string-name><surname>Feige</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Spiegelhalder</surname>
<given-names>K</given-names></string-name>, et al. <article-title>HPA axis activity in patients with chronic insomnia: a systematic review and meta-analysis of case–control studies</article-title>. <source><italic toggle="yes">Sleep Med Rev</italic></source>. <year>2022</year>;<volume>62</volume>:<fpage>101588</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.smrv.2022.101588</pub-id><pub-id pub-id-type="pmid">35091194</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0088">
        <label>88.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Jeanneteau</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Borie</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Chao</surname>
<given-names>MV</given-names></string-name>, <string-name><surname>Garabedian</surname>
<given-names>MJ</given-names></string-name>. <article-title>Bridging the gap between brain-derived neurotrophic factor and glucocorticoid effects on brain networks</article-title>. <source><italic toggle="yes">Neuroendocrinology</italic></source>. <year>2019</year>;<volume>109</volume>(<issue>3</issue>):<fpage>277</fpage>–<lpage>284</lpage>. doi:<pub-id pub-id-type="doi">10.1159/000496392</pub-id><pub-id pub-id-type="pmid">30572337</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0089">
        <label>89.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Suri</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Vaidya</surname>
<given-names>VA</given-names></string-name>. <article-title>Glucocorticoid regulation of brain-derived neurotrophic factor: relevance to hippocampal structural and functional plasticity</article-title>. <source><italic toggle="yes">Neuroscience</italic></source>. <year>2013</year>;<volume>239</volume>:<fpage>196</fpage>–<lpage>213</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuroscience.2012.08.065</pub-id><pub-id pub-id-type="pmid">22967840</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0090">
        <label>90.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Chiba</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Numakawa</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Ninomiya</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Richards</surname>
<given-names>MC</given-names></string-name>, <string-name><surname>Wakabayashi</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Kunugi</surname>
<given-names>H</given-names></string-name>. <article-title>Chronic restraint stress causes anxiety- and depression-like behaviors, downregulates glucocorticoid receptor expression, and attenuates glutamate release induced by brain-derived neurotrophic factor in the prefrontal cortex</article-title>. <source><italic toggle="yes">Prog Neuro Psychopharmacol Biol Psychiatry</italic></source>. <year>2012</year>;<volume>39</volume>(<issue>1</issue>):<fpage>112</fpage>–<lpage>119</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.pnpbp.2012.05.018</pub-id></mixed-citation>
      </ref>
      <ref id="cit0091">
        <label>91.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Naert</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Ixart</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Maurice</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Tapia-Arancibia</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Givalois</surname>
<given-names>L</given-names></string-name>. <article-title>Brain-derived neurotrophic factor and hypothalamic-pituitary-adrenal axis adaptation processes in a depressive-like state induced by chronic restraint stress</article-title>. <source><italic toggle="yes">Mol Cell Neurosci</italic></source>. <year>2011</year>;<volume>46</volume>(<issue>1</issue>):<fpage>55</fpage>–<lpage>66</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.mcn.2010.08.006</pub-id><pub-id pub-id-type="pmid">20708081</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0092">
        <label>92.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Ambrus</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Lindqvist</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Träskman-Bendz</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Å</surname>
<given-names>W</given-names></string-name>. <article-title>Hypothalamic–pituitary–adrenal axis hyperactivity is associated with decreased brain-derived neurotrophic factor in female suicide attempters</article-title>. <source><italic toggle="yes">Nordic J Psychiatry</italic></source>. <year>2016</year>;<volume>70</volume>(<issue>8</issue>):<fpage>575</fpage>–<lpage>581</lpage>. doi:<pub-id pub-id-type="doi">10.1080/08039488.2016.1184310</pub-id></mixed-citation>
      </ref>
      <ref id="cit0093">
        <label>93.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Onen Sertoz</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Tolga Binbay</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Koylu</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Noyan</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Yildirim</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Elbi Mete</surname>
<given-names>H</given-names></string-name>. <article-title>The role of BDNF and HPA axis in the neurobiology of burnout syndrome</article-title>. <source><italic toggle="yes">Prog Neuropsychopharmacol Biol Psychiatry</italic></source>. <year>2008</year>;<volume>32</volume>(<issue>6</issue>):<fpage>1459</fpage>–<lpage>1465</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.pnpbp.2008.05.001</pub-id><pub-id pub-id-type="pmid">18541357</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0094">
        <label>94.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Suliman</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Hemmings</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Seedat</surname>
<given-names>S</given-names></string-name>. <article-title>Brain-Derived Neurotrophic Factor (BDNF) protein levels in anxiety disorders: systematic review and meta-regression analysis. Original Research</article-title>. <source><italic toggle="yes">Front Integrat Neurosci</italic></source>. <year>2013</year>;<volume>7</volume>. doi:<pub-id pub-id-type="doi">10.3389/fnint.2013.00055</pub-id></mixed-citation>
      </ref>
      <ref id="cit0095">
        <label>95.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Baik</surname>
<given-names>J-H</given-names></string-name>. <article-title>Stress and the dopaminergic reward system</article-title>. <source><italic toggle="yes">Exp Mol Med</italic></source>. <year>2020</year>;<volume>52</volume>(<issue>12</issue>):<fpage>1879</fpage>–<lpage>1890</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s12276-020-00532-4</pub-id><pub-id pub-id-type="pmid">33257725</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0096">
        <label>96.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Rosenblum</surname>
<given-names>M</given-names></string-name>. <article-title>Substance abuse and insomnia</article-title>. <source><italic toggle="yes">Minn Med</italic></source>. <year>2017</year>;<volume>100</volume>(<issue>3</issue>):<fpage>38</fpage>–<lpage>39</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0097">
        <label>97.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Furihata</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Saitoh</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Otsuki</surname>
<given-names>R</given-names></string-name>, et al. <article-title>Association between reduced serum BDNF levels and insomnia with short sleep duration among female hospital nurses</article-title>. <source><italic toggle="yes">Sleep Med</italic></source>. <year>2020</year>;<volume>68</volume>:<fpage>167</fpage>–<lpage>172</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.sleep.2019.12.011</pub-id><pub-id pub-id-type="pmid">32044553</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0098">
        <label>98.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Giese</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Unternährer</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Hüttig</surname>
<given-names>H</given-names></string-name>, et al. <article-title>BDNF: an indicator of insomnia?</article-title>
<source><italic toggle="yes">Mol Psychiatry</italic></source>. <year>2014</year>;<volume>19</volume>(<issue>2</issue>):<fpage>151</fpage>–<lpage>152</lpage>. doi:<pub-id pub-id-type="doi">10.1038/mp.2013.10</pub-id><pub-id pub-id-type="pmid">23399916</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0099">
        <label>99.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Gabryelska</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Turkiewicz</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Ditmer</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Sochal</surname>
<given-names>M</given-names></string-name>. <article-title>Neurotrophins in the neuropathophysiology, course, and complications of obstructive sleep apnea—a narrative review</article-title>. <source><italic toggle="yes">Int J Mol Sci</italic></source>. <year>2023</year>;<volume>24</volume>(<issue>3</issue>):<fpage>1808</fpage>. doi:<pub-id pub-id-type="doi">10.3390/ijms24031808</pub-id><pub-id pub-id-type="pmid">36768132</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0100">
        <label>100.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Brunoni</surname>
<given-names>AR</given-names></string-name>, <string-name><surname>Lopes</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Fregni</surname>
<given-names>F</given-names></string-name>. <article-title>A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression</article-title>. <source><italic toggle="yes">Int J Neuropsychopharmacol</italic></source>. <year>2008</year>;<volume>11</volume>(<issue>8</issue>):<fpage>1169</fpage>–<lpage>1180</lpage>. doi:<pub-id pub-id-type="doi">10.1017/S1461145708009309</pub-id><pub-id pub-id-type="pmid">18752720</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0101">
        <label>101.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Fan</surname>
<given-names>TT</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>WH</given-names></string-name>, <string-name><surname>Shi</surname>
<given-names>L</given-names></string-name>, et al. <article-title>Objective sleep duration is associated with cognitive deficits in primary insomnia: BDNF may play a role</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2019</year>;<volume>42</volume>(<issue>1</issue>). doi:<pub-id pub-id-type="doi">10.1093/sleep/zsy192</pub-id></mixed-citation>
      </ref>
      <ref id="cit0102">
        <label>102.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Sanchez-Garcia</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Moreno-Tamayo</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Ramirez-Aldana</surname>
<given-names>R</given-names></string-name>, et al. <article-title>Insomnia impairs both the Pro-BDNF and the BDNF levels similarly to older adults with cognitive decline: an exploratory study</article-title>. <source><italic toggle="yes">Int J Mol Sci</italic></source>. <year>2023</year>;<volume>24</volume>(<issue>8</issue>):<fpage>7387</fpage>. doi:<pub-id pub-id-type="doi">10.3390/ijms24087387</pub-id><pub-id pub-id-type="pmid">37108547</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0103">
        <label>103.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Satyanarayanan</surname>
<given-names>SK</given-names></string-name>, <string-name><surname>Chien</surname>
<given-names>YC</given-names></string-name>, <string-name><surname>Chang</surname>
<given-names>JP</given-names></string-name>, et al. <article-title>Melatonergic agonist regulates circadian clock genes and peripheral inflammatory and neuroplasticity markers in patients with depression and anxiety</article-title>. <source><italic toggle="yes">Brain Behav Immun</italic></source>. <year>2020</year>;<volume>85</volume>:<fpage>142</fpage>–<lpage>151</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bbi.2019.03.003</pub-id><pub-id pub-id-type="pmid">30851380</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0104">
        <label>104.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Zhang</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>YX</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>ZZ</given-names></string-name>, et al. <article-title>Astroglial mechanisms underlying chronic insomnia disorder: a clinical study</article-title>. <source><italic toggle="yes">Nat Sci Sleep</italic></source>. <year>2020</year>;<volume>12</volume>:<fpage>693</fpage>–<lpage>704</lpage>. doi:<pub-id pub-id-type="doi">10.2147/nss.S263528</pub-id><pub-id pub-id-type="pmid">33117005</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0105">
        <label>105.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Mikoteit</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Brand</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Eckert</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Holsboer-Trachsler</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Beck</surname>
<given-names>J</given-names></string-name>. <article-title>Brain-derived neurotrophic factor is a biomarker for subjective insomnia but not objectively assessable poor sleep continuity</article-title>. <source><italic toggle="yes">J Psychiatr Res</italic></source>. <year>2019</year>;<volume>110</volume>:<fpage>103</fpage>–<lpage>109</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jpsychires.2018.12.020</pub-id><pub-id pub-id-type="pmid">30616157</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0106">
        <label>106.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Deuschle</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Schredl</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Wisch</surname>
<given-names>C</given-names></string-name>, et al. <article-title>Serum brain-derived neurotrophic factor (BDNF) in sleep-disordered patients: relation to sleep stage N3 and rapid eye movement (REM) sleep across diagnostic entities</article-title>. <source><italic toggle="yes">J Sleep Res</italic></source>. <year>2018</year>;<volume>27</volume>(<issue>1</issue>):<fpage>73</fpage>–<lpage>77</lpage>. doi:<pub-id pub-id-type="doi">10.1111/jsr.12577</pub-id><pub-id pub-id-type="pmid">28656632</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0107">
        <label>107.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Schmitt</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Holsboer-Trachsler</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Eckert</surname>
<given-names>A</given-names></string-name>. <article-title>BDNF in sleep, insomnia, and sleep deprivation</article-title>. <source><italic toggle="yes">Ann Med</italic></source>. <year>2016</year>;<volume>48</volume>(<issue>1–2</issue>):<fpage>42</fpage>–<lpage>51</lpage>. doi:<pub-id pub-id-type="doi">10.3109/07853890.2015.1131327</pub-id><pub-id pub-id-type="pmid">26758201</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0108">
        <label>108.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Xue</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>Z</given-names></string-name>, et al. <article-title>Paradoxical sleep deprivation aggravates and prolongs incision-induced pain hypersensitivity via BDNF signaling-mediated descending facilitation in rats</article-title>. <source><italic toggle="yes">Neurochem Res</italic></source>. <year>2018</year>;<volume>43</volume>(<issue>12</issue>):<fpage>2353</fpage>–<lpage>2361</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s11064-018-2660-2</pub-id><pub-id pub-id-type="pmid">30324331</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0109">
        <label>109.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Musazzi</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Treccani</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Popoli</surname>
<given-names>M</given-names></string-name>. <article-title>Functional and structural remodeling of glutamate synapses in prefrontal and frontal cortex induced by behavioral stress</article-title>. <source><italic toggle="yes">Front Psychiatry</italic></source>. <year>2015</year>;<volume>6</volume>:<fpage>60</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fpsyt.2015.00060</pub-id><pub-id pub-id-type="pmid">25964763</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0110">
        <label>110.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Cunha</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Brambilla</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Thomas</surname>
<given-names>KL</given-names></string-name>. <article-title>A simple role for BDNF in learning and memory?</article-title>
<source><italic toggle="yes">Front Mol Neurosci</italic></source>. <year>2010</year>;<volume>3</volume>:<fpage>1</fpage>. doi:<pub-id pub-id-type="doi">10.3389/neuro.02.001.2010</pub-id><pub-id pub-id-type="pmid">20162032</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0111">
        <label>111.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Frank</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Ventimiglia</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Anderson</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Lindsay</surname>
<given-names>RM</given-names></string-name>, <string-name><surname>Rudge</surname>
<given-names>JS</given-names></string-name>. <article-title>BDN F down-regulates neurotrophin responsiveness, TrkB protein and TrkB mRNA levels in cultured rat hippocampal neurons</article-title>. <source><italic toggle="yes">Eur J Neurosci</italic></source>. <year>1996</year>;<volume>8</volume>(<issue>6</issue>):<fpage>1220</fpage>–<lpage>1230</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1460-9568.1996.tb01290.x</pub-id><pub-id pub-id-type="pmid">8752592</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0112">
        <label>112.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Bellesi</surname>
<given-names>M</given-names></string-name>, <string-name><surname>de Vivo</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Chini</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Gilli</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Tononi</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Cirelli</surname>
<given-names>C</given-names></string-name>. <article-title>Sleep loss promotes astrocytic phagocytosis and microglial activation in mouse cerebral cortex</article-title>. <source><italic toggle="yes">J Neurosci</italic></source>. <year>2017</year>;<volume>37</volume>(<issue>21</issue>):<fpage>5263</fpage>–<lpage>5273</lpage>. doi:<pub-id pub-id-type="doi">10.1523/jneurosci.3981-16.2017</pub-id><pub-id pub-id-type="pmid">28539349</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0113">
        <label>113.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Khalaji</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Behnoush</surname>
<given-names>AH</given-names></string-name>, <string-name><surname>Shobeiri</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Saeedian</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Teixeira</surname>
<given-names>AL</given-names></string-name>, <string-name><surname>Rezaei</surname>
<given-names>N</given-names></string-name>. <article-title>Association between brain-derived neurotrophic factor levels and obstructive sleep apnea: a systematic review and meta-analysis</article-title>. <source><italic toggle="yes">Sleep Breath</italic></source>. <year>2023</year>;<volume>27</volume>(<issue>3</issue>):<fpage>829</fpage>–<lpage>841</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s11325-022-02707-x</pub-id><pub-id pub-id-type="pmid">36115874</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0114">
        <label>114.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Nordahl</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Havnen</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Hansen</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Ost</surname>
<given-names>LG</given-names></string-name>, <string-name><surname>Kvale</surname>
<given-names>G</given-names></string-name>. <article-title>Sleep disturbances in treatment-seeking OCD-patients: changes after concentrated exposure treatment</article-title>. <source><italic toggle="yes">Scand J Psychol</italic></source>. <year>2018</year>;<volume>59</volume>(<issue>2</issue>):<fpage>186</fpage>–<lpage>191</lpage>. doi:<pub-id pub-id-type="doi">10.1111/sjop.12417</pub-id><pub-id pub-id-type="pmid">29244201</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0115">
        <label>115.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Plante</surname>
<given-names>DT</given-names></string-name>, <string-name><surname>Jensen</surname>
<given-names>JE</given-names></string-name>, <string-name><surname>Winkelman</surname>
<given-names>JW</given-names></string-name>. <article-title>The role of GABA in primary insomnia</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2012</year>;<volume>35</volume>(<issue>6</issue>):<fpage>741</fpage>–<lpage>742</lpage>. doi:<pub-id pub-id-type="doi">10.5665/sleep.1854</pub-id><pub-id pub-id-type="pmid">22654187</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0116">
        <label>116.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Morgan</surname>
<given-names>PT</given-names></string-name>, <string-name><surname>Pace-Schott</surname>
<given-names>EF</given-names></string-name>, <string-name><surname>Mason</surname>
<given-names>GF</given-names></string-name>, et al. <article-title>Cortical GABA levels in primary insomnia</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2012</year>;<volume>35</volume>(<issue>6</issue>):<fpage>807</fpage>–<lpage>814</lpage>. doi:<pub-id pub-id-type="doi">10.5665/sleep.1880</pub-id><pub-id pub-id-type="pmid">22654200</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0117">
        <label>117.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Hepsomali</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Groeger</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Nishihira</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Scholey</surname>
<given-names>A</given-names></string-name>. <article-title>Effects of Oral Gamma-Aminobutyric Acid (GABA) administration on stress and sleep in humans: a systematic review</article-title>. <source><italic toggle="yes">Front Neurosci</italic></source>. <year>2020</year>;<volume>14</volume>:<fpage>923</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fnins.2020.00923</pub-id><pub-id pub-id-type="pmid">33041752</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0118">
        <label>118.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Scammell</surname>
<given-names>TE</given-names></string-name>, <string-name><surname>Jackson</surname>
<given-names>AC</given-names></string-name>, <string-name><surname>Franks</surname>
<given-names>NP</given-names></string-name>, <string-name><surname>Wisden</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Dauvilliers</surname>
<given-names>Y</given-names></string-name>. <article-title>Histamine: neural circuits and new medications</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2019</year>;<volume>42</volume>(<issue>1</issue>):<fpage>zsy183</fpage>. doi:<pub-id pub-id-type="doi">10.1093/sleep/zsy183</pub-id><pub-id pub-id-type="pmid">30239935</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0119">
        <label>119.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Mormile</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Mazzei</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Vittori</surname>
<given-names>G</given-names></string-name>, <string-name><surname>de Michele</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Squarcia</surname>
<given-names>U</given-names></string-name>. <article-title>Insomnia and shift-work sleep disorder: a crosstalk between glutamate excitotoxicity and decreased GABAergic neurotransmission?</article-title>
<source><italic toggle="yes">Sleep Biol Rhythms</italic></source>. <year>2012</year>;<volume>10</volume>(<issue>4</issue>):<fpage>340</fpage>–<lpage>341</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1479-8425.2012.00574.x</pub-id></mixed-citation>
      </ref>
      <ref id="cit0120">
        <label>120.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Wang</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Reddy</surname>
<given-names>PH</given-names></string-name>. <article-title>Role of glutamate and NMDA receptors in Alzheimer’s disease</article-title>. <source><italic toggle="yes">J Alzheimers Dis</italic></source>. <year>2017</year>;<volume>57</volume>(<issue>4</issue>):<fpage>1041</fpage>–<lpage>1048</lpage>. doi:<pub-id pub-id-type="doi">10.3233/jad-160763</pub-id><pub-id pub-id-type="pmid">27662322</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0121">
        <label>121.</label>
        <mixed-citation publication-type="journal"><string-name><surname>He</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Glutamate</surname>
<given-names>QS</given-names></string-name>. <article-title>Glutamate transporters, and circadian rhythm sleep disorders in neurodegenerative diseases</article-title>. <source><italic toggle="yes">ACS Chem Neurosci</italic></source>. <year>2019</year>;<volume>10</volume>(<issue>1</issue>):<fpage>175</fpage>–<lpage>181</lpage>. doi:<pub-id pub-id-type="doi">10.1021/acschemneuro.8b00419</pub-id><pub-id pub-id-type="pmid">30485059</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0122">
        <label>122.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Novati</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Hulshof</surname>
<given-names>HJ</given-names></string-name>, <string-name><surname>Granic</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Meerlo</surname>
<given-names>P</given-names></string-name>. <article-title>Chronic partial sleep deprivation reduces brain sensitivity to glutamate N-methyl-D-aspartate receptor-mediated neurotoxicity</article-title>. <source><italic toggle="yes">J Sleep Res</italic></source>. <year>2012</year>;<volume>21</volume>(<issue>1</issue>):<fpage>3</fpage>–<lpage>9</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1365-2869.2011.00932.x</pub-id><pub-id pub-id-type="pmid">21672070</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0123">
        <label>123.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Gotoh</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Masaki</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Chiba</surname>
<given-names>S</given-names></string-name>, et al. <article-title>Brain-derived neurotrophic factor, corticotropin-releasing factor, and hypothalamic neuronal histamine interact to regulate feeding behavior</article-title>. <source><italic toggle="yes">J Neurochem</italic></source>. <year>2013</year>;<volume>125</volume>(<issue>4</issue>):<fpage>588</fpage>–<lpage>598</lpage>. doi:<pub-id pub-id-type="doi">10.1111/jnc.12213</pub-id><pub-id pub-id-type="pmid">23432085</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0124">
        <label>124.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Ren</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Fang</surname>
<given-names>X</given-names></string-name>, et al. <article-title>Correlation of Orexin-A and brain-derived neurotrophic factor levels in metabolic syndrome and cognitive impairment in schizophrenia treated with clozapine</article-title>. <source><italic toggle="yes">Neurosci Letters</italic></source>. <year>2022</year>;<volume>782</volume>:<fpage>136695</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neulet.2022.136695</pub-id></mixed-citation>
      </ref>
      <ref id="cit0125">
        <label>125.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Mogavero</surname>
<given-names>MP</given-names></string-name>, <string-name><surname>Silvani</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Lanza</surname>
<given-names>G</given-names></string-name>, <string-name><surname>DelRosso</surname>
<given-names>LM</given-names></string-name>, <string-name><surname>Ferini-Strambi</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Ferri</surname>
<given-names>R</given-names></string-name>. <article-title>Targeting orexin receptors for the treatment of insomnia: from physiological mechanisms to current clinical evidence and recommendations</article-title>. <source><italic toggle="yes">Nat Sci Sleep</italic></source>. <year>2023</year>;<volume>15</volume>:<fpage>17</fpage>–<lpage>38</lpage>. doi:<pub-id pub-id-type="doi">10.2147/nss.S201994</pub-id><pub-id pub-id-type="pmid">36713640</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0126">
        <label>126.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Saper</surname>
<given-names>CB</given-names></string-name>, <string-name><surname>Chou</surname>
<given-names>TC</given-names></string-name>, <string-name><surname>Scammell</surname>
<given-names>TE</given-names></string-name>. <article-title>The sleep switch: hypothalamic control of sleep and wakefulness</article-title>. <source><italic toggle="yes">Trends Neurosci</italic></source>. <year>2001</year>;<volume>24</volume>(<issue>12</issue>):<fpage>726</fpage>–<lpage>731</lpage>. doi:<pub-id pub-id-type="doi">10.1016/s0166-2236(00)02002-6</pub-id><pub-id pub-id-type="pmid">11718878</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0127">
        <label>127.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Wang</surname>
<given-names>Z-J</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>J-F</given-names></string-name>. <article-title>The molecular basis of insomnia: implication for therapeutic approaches</article-title>. <source><italic toggle="yes">Drug Dev Res</italic></source>. <year>2016</year>;<volume>77</volume>(<issue>8</issue>):<fpage>427</fpage>–<lpage>436</lpage>. doi:<pub-id pub-id-type="doi">10.1002/ddr.21338</pub-id><pub-id pub-id-type="pmid">27594319</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0128">
        <label>128.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Palagini</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Geoffroy</surname>
<given-names>PA</given-names></string-name>, <string-name><surname>Gehrman</surname>
<given-names>PR</given-names></string-name>, <string-name><surname>Miniati</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Gemignani</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Riemann</surname>
<given-names>D</given-names></string-name>. <article-title>Potential genetic and epigenetic mechanisms in insomnia: a systematic review</article-title>. <source><italic toggle="yes">J Sleep Res</italic></source>. <year>2023</year>;<fpage>e13868</fpage>. doi:<pub-id pub-id-type="doi">10.1111/jsr.13868</pub-id><pub-id pub-id-type="pmid">36918298</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0129">
        <label>129.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Stein</surname>
<given-names>MB</given-names></string-name>, <string-name><surname>McCarthy</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>CY</given-names></string-name>, et al. <article-title>Genome-wide analysis of insomnia disorder</article-title>. <source><italic toggle="yes">Mol Psychiatry</italic></source>. <year>2018</year>;<volume>23</volume>(<issue>11</issue>):<fpage>2238</fpage>–<lpage>2250</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41380-018-0033-5</pub-id><pub-id pub-id-type="pmid">29520036</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0130">
        <label>130.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Palagini</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Drake</surname>
<given-names>CL</given-names></string-name>, <string-name><surname>Gehrman</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Meerlo</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Riemann</surname>
<given-names>D</given-names></string-name>. <article-title>Early-life origin of adult insomnia: does prenatal-early-life stress play a role?</article-title>
<source><italic toggle="yes">Sleep Med</italic></source>. <year>2015</year>;<volume>16</volume>(<issue>4</issue>):<fpage>446</fpage>–<lpage>456</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.sleep.2014.10.013</pub-id><pub-id pub-id-type="pmid">25799941</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0131">
        <label>131.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Van Someren</surname>
<given-names>EJW</given-names></string-name>. <article-title>Brain mechanisms of insomnia: new perspectives on causes and consequences</article-title>. <source><italic toggle="yes">Physiol Rev</italic></source>. <year>2021</year>;<volume>101</volume>(<issue>3</issue>):<fpage>995</fpage>–<lpage>1046</lpage>. doi:<pub-id pub-id-type="doi">10.1152/physrev.00046.2019</pub-id><pub-id pub-id-type="pmid">32790576</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0132">
        <label>132.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Karg</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Burmeister</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Shedden</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Sen</surname>
<given-names>S</given-names></string-name>. <article-title>The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: evidence of genetic moderation</article-title>. <source><italic toggle="yes">Arch Gen Psychiatry</italic></source>. <year>2011</year>;<volume>68</volume>(<issue>5</issue>):<fpage>444</fpage>–<lpage>454</lpage>. doi:<pub-id pub-id-type="doi">10.1001/archgenpsychiatry.2010.189</pub-id><pub-id pub-id-type="pmid">21199959</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0133">
        <label>133.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Palagini</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Biber</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Riemann</surname>
<given-names>D</given-names></string-name>. <article-title>The genetics of insomnia--evidence for epigenetic mechanisms?</article-title>
<source><italic toggle="yes">Sleep Med Rev</italic></source>. <year>2014</year>;<volume>18</volume>(<issue>3</issue>):<fpage>225</fpage>–<lpage>235</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.smrv.2013.05.002</pub-id><pub-id pub-id-type="pmid">23932332</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0134">
        <label>134.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Hamet</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Tremblay</surname>
<given-names>J</given-names></string-name>. <article-title>Genetics of the sleep-wake cycle and its disorders</article-title>. <source><italic toggle="yes">Metabolism</italic></source>. <year>2006</year>;<volume>55</volume>:<fpage>S7</fpage>–<lpage>S12</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.metabol.2006.07.006</pub-id><pub-id pub-id-type="pmid">16979429</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0135">
        <label>135.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Wang</surname>
<given-names>ZJ</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>JF</given-names></string-name>. <article-title>The molecular basis of insomnia: implication for therapeutic approaches</article-title>. <source><italic toggle="yes">Drug Dev Res</italic></source>. <year>2016</year>;<volume>77</volume>(<issue>8</issue>):<fpage>427</fpage>–<lpage>436</lpage>. doi:<pub-id pub-id-type="doi">10.1002/ddr.21338</pub-id><pub-id pub-id-type="pmid">27594319</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0136">
        <label>136.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Sammallahti</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Koopman-Verhoeff</surname>
<given-names>ME</given-names></string-name>, <string-name><surname>Binter</surname>
<given-names>A-C</given-names></string-name>, et al. <article-title>Longitudinal associations of DNA methylation and sleep in children: a meta-analysis</article-title>. <source><italic toggle="yes">Clin Epigenet</italic></source>. <year>2022</year>;<volume>14</volume>(<issue>1</issue>):<fpage>83</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s13148-022-01298-4</pub-id></mixed-citation>
      </ref>
      <ref id="cit0137">
        <label>137.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Koopman-Verhoeff</surname>
<given-names>ME</given-names></string-name>, <string-name><surname>Mulder</surname>
<given-names>RH</given-names></string-name>, <string-name><surname>Saletin</surname>
<given-names>JM</given-names></string-name>, et al. <article-title>Genome-wide DNA methylation patterns associated with sleep and mental health in children: a population-based study</article-title>. <source><italic toggle="yes">J Child Psychol Psychiatry</italic></source>. <year>2020</year>;<volume>61</volume>(<issue>10</issue>):<fpage>1061</fpage>–<lpage>1069</lpage>. doi:<pub-id pub-id-type="doi">10.1111/jcpp.13252</pub-id><pub-id pub-id-type="pmid">32361995</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0138">
        <label>138.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Ancelin</surname>
<given-names>M-L</given-names></string-name>, <string-name><surname>Jaussent</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Ritchie</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Besset</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Ryan</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Dauvilliers</surname>
<given-names>Y</given-names></string-name>. <article-title>Brain-derived neurotrophic factor (BDNF) variants and promoter I methylation are associated with prolonged nocturnal awakenings in older adults</article-title>. <source><italic toggle="yes">J Sleep Res</italic></source>. <year>2023</year>;<volume>32</volume>(<issue>4</issue>):<fpage>e13838</fpage>. doi:<pub-id pub-id-type="doi">10.1111/jsr.13838</pub-id><pub-id pub-id-type="pmid">36737401</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0139">
        <label>139.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Lahtinen</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Puttonen</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Vanttola</surname>
<given-names>P</given-names></string-name>, et al. <article-title>A distinctive DNA methylation pattern in insufficient sleep</article-title>. <source><italic toggle="yes">Sci Rep</italic></source>. <year>2019</year>;<volume>9</volume>(<issue>1</issue>):<fpage>1193</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41598-018-38009-0</pub-id><pub-id pub-id-type="pmid">30718923</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0140">
        <label>140.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Peter</surname>
<given-names>CE</given-names></string-name>, <string-name><surname>Antony</surname>
<given-names>JB</given-names></string-name>, <string-name><surname>Mark</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Janet</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Clive</surname>
<given-names>M</given-names></string-name>, <string-name><surname>John</surname>
<given-names>EJG</given-names></string-name>. <article-title>Sleep disturbance and daytime sleepiness predict vascular dementia</article-title>. <source><italic toggle="yes">J Epidemiol Community Health</italic></source>. <year>2011</year>;<volume>65</volume>(<issue>9</issue>):<fpage>820</fpage>. doi:<pub-id pub-id-type="doi">10.1136/jech.2009.100503</pub-id><pub-id pub-id-type="pmid">20675705</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0141">
        <label>141.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Elder</surname>
<given-names>GJ</given-names></string-name>, <string-name><surname>Lazar</surname>
<given-names>AS</given-names></string-name>, <string-name><surname>Alfonso-Miller</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Taylor</surname>
<given-names>JP</given-names></string-name>. <article-title>Sleep disturbances in Lewy body dementia: a systematic review</article-title>. <source><italic toggle="yes">Int J Geriatr Psychiatry</italic></source>. <year>2022</year>;<volume>37</volume>(<issue>10</issue>). doi:<pub-id pub-id-type="doi">10.1002/gps.5814</pub-id></mixed-citation>
      </ref>
      <ref id="cit0142">
        <label>142.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Lloret</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Cervera-Ferri</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Nepomuceno</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Monllor</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Esteve</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Lloret</surname>
<given-names>A</given-names></string-name>. <article-title>Is sleep disruption a cause or consequence of Alzheimer’s disease? Reviewing its possible role as a biomarker</article-title>. <source><italic toggle="yes">Int J Mol Sci</italic></source>. <year>2020</year>;<volume>21</volume>(<issue>3</issue>):<fpage>1168</fpage>. doi:<pub-id pub-id-type="doi">10.3390/ijms21031168</pub-id><pub-id pub-id-type="pmid">32050587</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0143">
        <label>143.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Shen</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Lv</surname>
<given-names>QK</given-names></string-name>, <string-name><surname>Xie</surname>
<given-names>WY</given-names></string-name>, et al. <article-title>Circadian disruption and sleep disorders in neurodegeneration</article-title>. <source><italic toggle="yes">Transl Neurodegener</italic></source>. <year>2023</year>;<volume>12</volume>(<issue>1</issue>):<fpage>8</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s40035-023-00340-6</pub-id><pub-id pub-id-type="pmid">36782262</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0144">
        <label>144.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Johnson</surname>
<given-names>KA</given-names></string-name>, <string-name><surname>Fox</surname>
<given-names>NC</given-names></string-name>, <string-name><surname>Sperling</surname>
<given-names>RA</given-names></string-name>, <string-name><surname>Klunk</surname>
<given-names>WE</given-names></string-name>. <article-title>Brain imaging in Alzheimer disease</article-title>. <source><italic toggle="yes">Cold Spring Harb Perspect Med</italic></source>. <year>2012</year>;<volume>2</volume>(<issue>4</issue>):<fpage>a006213</fpage>. doi:<pub-id pub-id-type="doi">10.1101/cshperspect.a006213</pub-id><pub-id pub-id-type="pmid">22474610</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0145">
        <label>145.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Leerssen</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Blanken</surname>
<given-names>TF</given-names></string-name>, <string-name><surname>Pozzi</surname>
<given-names>E</given-names></string-name>, et al. <article-title>Brain structural correlates of insomnia severity in 1053 individuals with major depressive disorder: results from the ENIGMA MDD Working Group</article-title>. <source><italic toggle="yes">Transl Psychiatry</italic></source>. <year>2020</year>;<volume>10</volume>(<issue>1</issue>):<fpage>425</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41398-020-01109-5</pub-id><pub-id pub-id-type="pmid">33293520</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0146">
        <label>146.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Cechova</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Angelucci</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Markova</surname>
<given-names>H</given-names></string-name>, et al. <article-title>Ratio of serum proBDNF to BDNF and its association with cognitive performance and brain morphometry in mild cognitive impairment</article-title>. <source><italic toggle="yes">Alzheimer’s Dementia</italic></source>. <year>2020</year>;<volume>16</volume>(<issue>S6</issue>):<fpage>e046340</fpage>. doi:<pub-id pub-id-type="doi">10.1002/alz.046340</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
